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ABSTRACT 
Ultrasound can be focused into deep tissues with millimeter precision to perform non-invasive 
ablative therapy for diseases such as cancer. In most cases, this ablation uses high intensity 
ultrasound to deposit non-selective thermal or mechanical energy at the ultrasound focus, 
damaging both healthy bystander tissue and cancer cells. Here we describe an alternative low 
intensity pulsed ultrasound approach known as “oncotripsy” that leverages the distinct mechanical 
properties of neoplastic cells to achieve inherent cancer selectivity.  We show that when applied 
at a specific frequency and pulse duration, focused ultrasound selectively disrupts a panel of breast, 
colon, and leukemia cancer cell models in suspension without significantly damaging healthy 
immune or red blood cells. Mechanistic experiments reveal that the formation of acoustic standing 
waves and the emergence of cell-seeded cavitation lead to cytoskeletal disruption, expression of 
apoptotic markers, and cell death.  The inherent selectivity of this low intensity pulsed ultrasound 
approach offers a potentially safer and thus more broadly applicable alternative to non-selective 
high intensity ultrasound ablation. 
In this dissertation, I describe the oncotripsy theory in its initial formulation, the experimental 
validation and investigation of testable predictions from that theory, and the refinement of said 
theory with new experimental evidence.  Throughout, I describe how careful modifications to the 
ultrasound waveform directly can significantly impact how the ultrasound bio-effects control, 
influence, or disrupt cells in a selective and controlled manner. 
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C h a p t e r  1   
 
ULTRASOUND AS A CANCER THERAPEUTIC MODALITY 
1.1 Introduction 
In this chapter, I will discuss the necessary background required to discuss ultrasound’s 
use as a cancer therapeutic modality.  First, I will provide an overview of the current state of cancer 
therapy and some key challenges that remain in the selective targeting of cancer cells necessary 
for safe and effective therapy.  Next, I will introduce ultrasound as a therapeutic modality, 
describing its history of medical use and characteristics that make it well suited for use in the 
human body.  Following this, I will provide an overview of the relevant acoustic physics that are 
necessary for understanding the interaction of ultrasound in the body.  Finally, I will conclude with 
a literature review including several clinical and pre-clinical applications of ultrasound as a cancer 
ablative tool, with a critical analysis of their shortcomings in addressing cancer therapy.  This 
chapter shall serve as an introduction into my dissertation about designing inherently cancer 
selective ultrasound waveforms. 
1.2 Advances in Cancer Therapy due to Enhanced Tumor Selectivity 
Cancer, a disease of rapidly dividing mutated human cells within the body, poses several 
unique challenges for clinicians.  Chief among them has developing a therapeutic modality that 
selectively destroys the cancer cells without harming the surrounding healthy cells in the body.  
Historically cancer therapies have used extremely radical surgical removals of afflicted body parts, 
and it was only in the late 1970s that the cytostatic chemotherapeutic regimes of bleomycin, 
vinblastine, or cisplatin became mainstays of cancer therapy coupled with local surgical 
interventions.  However, these therapies mechanism of action to target the cell cycle exerts 
significant stress on healthy cells in the body and thus induces significant side effects.  The dosages 
and treatment regimens are constantly limited in their applicability due to the risks of excessive 
chemotherapy [1]. Over the past fifty years, cancer therapy has made great strides by developing 
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more precise therapeutic instruments and intervention that enhancing the capability to target the 
cancer cells selectively.  New chemotherapeutic agents including small molecule inhibitors or 
monoclonal antibodies, immunotherapeutic interventions such as chimeric antigen receptor T cells 
or checkpoint inhibitors, or additional biological therapies such as oncolytic viruses have all been 
developed to enhance tumor selectivity by taking advantage of the unique molecular biology of 
cancer cells for a more selective approach [2, 3].  Surgical interventions have also greatly 
benefitted from enhanced imaging technology [4] and new minimally invasive or fully non-
invasive ablative techniques [5] that can provide more spatially precise removal or ablation of 
cancer tissue from the human body.  By enhancing tumor selectivity, more aggressive therapeutic 
approaches can be taken without causing the harmful side effects.   
However, several cancers today continue to pose significant challenges for therapy, 
specifically because they are difficult to target selectively.  Many of the most therapeutically 
challenging cancers involve a solid tumor mass with poorly defined borders and invasion into 
healthy tissue [6, 7].  Moreover, the solid tumor microenvironment can have areas of high 
interstitial pressure and poor perfusion that prevent the penetration of chemotherapeutic agents [8].  
A clinical need exists for a new paradigm of targeting cancer cells that can be combined with 
existing therapies to enhance the selectivity and therefore applicability of cancer ablation.  In this 
dissertation, I plan to discuss how ultrasound can offer a solution for this clinical need. 
1.3 Therapeutic Ultrasound  
Ultrasound has been used widely in the medical field as a low-cost, real-time 
diagnostic/imaging system since the 1960s, and is considered a mature and well-developed area of 
research.  Ultrasound imaging is also an active and productive field of research with numerous 
breakthroughs in medical imaging including elastography, super resolution imaging, multiple 
element array transducers, functional/targeted contrast agents, and many other developments [9].   
Less known however are the numerous experimental and clinically proven applications of 
ultrasound as a therapeutic modality.  Acoustic energy can penetrate well within the body’s soft 
tissue, with a depth of up to 20 cm depending on the signal frequency, and can be focused to 
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deposit energy at depth within the body.  It also boasts sub-millimeter resolution, also dependent 
on frequency, which can be used for high-resolution images, but also to spatially target ultrasound 
used as therapy.   As such since its development, clinicians and researchers have found multiple 
therapeutic applications that take advantage of the unique physical properties of ultrasound [10].   
In fact, a historical review shows that therapeutic applications for ultrasound predated its 
use as an imaging modality.  The modern ultrasound transducer technology of sandwiched quartz 
piezoelectric crystals arose as an outgrowth of sonar technology used in World War 1 to detect 
submarines using echo-location [11].  This system generates ultrasound waves by applying an 
alternating electric voltage across a piezo-electric material.  In response to electrical stimulation, 
this piezo element undergoes tension and compression, thus generating pressure waves in the 
surrounding media.  With the advent of acoustic lenses, materials that could be shaped to allow 
the focusing of acoustic energy at depth within living tissue, therapeutic applications for acoustic 
energy quickly emerged.  The field of therapeutic ultrasound began in 1938, with devices that 
provided mild heating within the body as an anti-inflammatory therapy for conditions such as 
tendinitis or bursitis [12].  With further enhancements in focused ultrasound, the field of high 
intensity focused ultrasound was initiated in 1942.  High intensity focused ultrasound (HIFU) used 
continuous waves of high intensity ultrasound that was focused to a specific target region in the 
body to thermally ablate undesirable tissue, forming cigar-shaped thermal lesions [13].  This 
technique carried the risk of unintentional adverse bio-effects due to mis-targeting of the ablative 
beam.  However, the advantage of non-invasive tissue ablation led to some early use of the 
technology to ablate aberrant tissue in neurosurgery and later in tumor ablation [14].   In the 1960s, 
acoustic researchers began to investigate the mechanical effects of ultrasound, in the form of shock 
wave lithotripsy.  Short bursts of very high pressure ultrasound began to be used as a standard of 
care for the treatment of kidney and bladder stones, as it again allowed for non-invasive destruction 
of the undesired material [15].  The safety of both these mechanical and thermal ultrasound 
therapies greatly improved with improved imaging and guidance systems in the 1980s – in 
particularly MRI-guided focused ultrasound machines allowed for HIFU to be applied to a wider 
variety of cancer ablation scenarios [16].  Currently ultrasound therapy combines both the thermal 
and mechanical aspects of ultrasound and is clinically used in many non-invasive tissue ablation 
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practices, including several tumors where surgical access is challenging or complex, with research 
being performed in a variety of applications from disruption of blood clots [17] to enhanced drug 
delivery into tissue or through the blood-brain barrier [18].   A key challenge in the field of 
ultrasound as a tumor ablation approach, similarly to as described above for other cancer therapies, 
is achieving sufficient target specificity to reduce the risk of off-target ablation.  In this dissertation, 
we will discuss how careful control of the ultrasound waveform used may enhance the selectivity 
of the ultrasound ablative effect. 
1.4 Linear Acoustics: Reflection, Interference, Scattering, Refraction 
To provide a scientific context to our discussion of improving the safety margins for ultrasound 
ablation in cancer therapy, we will include a discussion of the acoustic properties of ultrasound 
and its relevance for producing bioeffects.  Sound is mechanical energy comprised of longitudinal 
pressure waves that pass through a material medium via the action of elastic stresses and involving 
local compression and rarefaction.  Ultrasound is a simply sound, where the frequency of these 
pressure waves is above the range of human hearing (>20 kHz).  At low acoustic pressure, 
ultrasound waves propagate as described through the linear wave equation, where the rate of 
change of particle velocity is proportional to the negative of the gradient of acoustic pressure.  This 
leads to a spatially distributed periodic pattern of compression and rarefaction that propagates 
through media with properties of compressibility and inertia.  The square of the speed of wave 
propagation in this linear approximation is directly proportional to the media’s pressure-density 
relation, and as such depends directly on the bulk material properties of the medium through with 
it propagates.  The product of the speed of sound of a medium and its density gives the acoustic 
impedance of that medium which is an important acoustic property that describes the reflection 
and transmission of sound at a boundary [19]. 
When the pressure wave reaches an interface, a wave is reflected back while another wave is 
transmitted.  The fraction of the wave that is reflected depends upon the mismatch of the 
impedance of the medium of the incident wave to that of the new medium the wave is entering, as 
demonstrated in Figure 1-1.  The incident wave, the transmitted wave, and the reflected wave, 
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must obey the wave equation as well as the continuity of pressure and normal particle velocity 
boundary conditions.  The human body contains many interfaces with slightly different acoustic 
impedances as organs, blood vessels, fat, and bones all have unique impedance values (Table 1-1).  
As such, an ultrasound wave transmitted into the body, will form many reflected signals that can 
be used to generate an image of the interior of the body [20].  The acoustic impedance also helps 
us to calculate the acoustic intensity of the ultrasound waveform.   Acoustic impedance (Z) relates 
the particle velocity (v0) to the acoustic pressure (p0) at that position in a sound wave through v0 = 
p0 / Z.  The instantaneous power per unit area in sound for a one-dimensional planar sound wave 
is I(t) = p(t) * v(t), which in this formulation becomes I(t) = p(t)^2 / Z.  Assuming a sinusoidal 
waveform, which is a valid assumption for low intensity, single frequency ultrasound waveforms, 
we arrive at an average intensity of Iavg = p02 / (2*Z) [19].  
The waves described above are traveling waves, with areas of compression and rarefaction 
that propagate forward over time.  The sum of two traveling waves passing opposite one another, 
which is achieved when a single standing wave reflects off a boundary and interferes with the 
incident wave, is referred to as a standing wave.  This occurs due to the linearity of acoustic 
pressure that occurs with low intensity ultrasound.  In these standing waves, a static spatial pattern 
of pressure nodes and anti-nodes appears as demonstrated in Figure 1-2.  At nodes, the acoustic 
pressure remains zero due to destructive interference between the incident and reflected wave.  At 
anti-nodes, the acoustic pressure oscillates with double the amplitude of the incident wave, due to 
the constructive interference of the two waves [19].   
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Figure 1-1 | Ultrasound Reflecting Off Of Interface 
An incident traveling sound wave (pressure pi) travels from tissue 1 (impedance Z1) to tissue 2 
(impedance Z2 = 2 * Z1).  Acoustic mismatch between tissue leads to generation of reflected 
traveling wave (pressure pr) and transmitted traveling wave (pt)  Reproduced from [19]. 
 
 
Figure 1-2 | Spatial Standing Wave Pattern 
The following is the plot of an acoustic standing wave f(x,t) = sin(πx)*cos(πx) demonstrating the 
nodes and antinodes of the pressure field evolving with time.  Reproduced from [19]. 
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Table 1-1 | Acoustic Impedance Values Per Tissue 
Acoustic impedance values, measured in Rayls (kg m-2 s-1) and non-linearity parameter (B/A) for 
various tissues and acoustic environments in the body.  Reproduced from [20]. 
Ultrasound also experiences scattering when it passes through heterogeneous media with 
characteristic containing multiple reflectors.  Scattering is required for ultrasound imaging as it is 
the interaction between the incident ultrasound wave and the various reflectors in the body that 
generates the reflected waves from which the ultrasound image is reconstructed.  Agents that 
induce scattering can be categorized as specular or diffractive based on their size.  Specular 
scattering agents generally have a characteristic length much larger than the wavelength of 
transmission, and cause a straightforward reflection of the ultrasound wave allowing the 
visualization of boundaries between different tissue types.  Diffractive agents include small cysts 
or micro calcifications and up the texture of the ultrasound image conveying information about the 
tissues that are being imaged.  Tissue in the body is largely heterogeneous, and different measures 
of heterogeneity can be representative of certain physiological or pathological conditions in organ 
systems.  As such, ultrasound can provide information about the interior of organ systems along 
with the interfaces between different structures within the body [20].  
8 
 
Ultrasound also has the capability to refract as it passes at an angle from one medium to 
another with a different acoustic impedance.  This is a consequence of the continuity of pressure 
and particle velocity required at the interface that maintains similar acoustic frequency.  Huygen’s 
principle, describing each point on a waveform as a point source for a wavelet that defines the next 
wavefront illustrates this process effectively in Figure 1-3.  The relevance of this for therapeutic 
ultrasound is that the capability to refract allows for the construction of acoustic lenses that can 
focus the acoustic energy into a small area.  This allows for the localization of the ultrasound 
energy necessary for targeting of ultrasound induced bioeffects [20].  Multi-element arrays also 
have the ability to use electronic steering to focus ultrasound energy at depth by implementing a 
programmed pattern of delays in each of their array elements, show in Figure 1-4.  Many modern 
therapeutic HIFU systems involve multi-element array to achieve spatially targeted therapeutic 
ultrasound ablation [19, 21].  
 
Figure 1-3 | Refraction of Ultrasound 
Ultrasound wavefronts refract when moving into a different medium.  Here with c2 < c1, the 
wavefront is refraction away from the normal of the boundary in an illustration of Huygen’s 
principle.  Reproduced from [20]. 
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Figure 1-4 | Multi-Element Beam Steering 
This illustration of a delayed-pulse phase array’s function shows 5 point source transducer 
generating a) plane waves, b) downward steered plane waves, c) focused beam by altering the 
delay on each of transducer element.  Reproduced from [19] 
 
1.5 Non-linear Acoustics: Attenuation, Radiation Force, Cavitation 
 However, with higher-pressure ultrasound waves, the linear model begins to breakdown, and 
a more complete model that incorporates some non-linearities helps to describe some of the key 
behavior of ultrasound waves relevant for tumor ablation.  Firstly, as the ultrasound passes through 
the body, it does not maintain all of its acoustic energy.  A portion of the acoustic energy is 
converted into heat and dissipated throughout the tissue that the ultrasound is passing through.  
This process is referred to as attenuation, and has consequences for penetration depth of ultrasound 
in the body, but also for ultrasound’s capability to be used as a thermal therapeutic agent.  The 
acoustic energy loss is caused by viscous losses as particles in the media oscillate due to the 
pressure wave.   Viscous friction converts some of this kinetic energy into heat, in a process highly 
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dependent on frequency and on the medium.  In general, attenuation is much stronger at higher 
frequencies, as demonstrated by the positive exponential in Table 1-2 [20].  As such, ultrasound 
imaging of deep tissue generally involves lower frequency ultrasound transducer.  Also, thermal 
ablation techniques tend to avoid very low frequencies in order to find a balance between 
penetration depth and heat generation [22].   
 
Table 1-2 | Ultrasound Attenuation Coefficients 
Attenuation coefficients for various tissue types, reproduced from [20] 
Ultrasound can also apply a constant linear force on tissue.  This is evident by observing the 
momentum balance that occurs at an interface where the ultrasound wave is completely reflected.  
A radiation pressure, force per area, is observed at this interface.  Similarly, in medium where the 
ultrasound wave is attenuated as it passes through said medium, there is a corresponding radiation 
pressure caused by the momentum balance on a theoretical interface that is formed as the pressure 
wave decays.  This pressure gradient corresponds to a force on the medium that leads to acoustic 
streaming or the acoustic radiation force [20].  The imaging modality known as ultrasound 
elastography takes advantage of this property to apply a shear force to tissue with a short pulse of 
high pressure ultrasound to apply a “tap” of radiation force to tissue, and then run diagnostic 
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imaging to observe the tissue responding to the applied shear force [23].  Acoustic radiation force 
has also been considered as a potential mechanism through which several low intensity ultrasound 
induced bioeffects have been observed.  For example, low intensity ultrasound has been shown to 
stimulate or inhibit neurons from firing, a process known as ultrasound neuromodulation [24].  
One potential theory for this mechanism, which is still not well understood, is acoustic radiation 
force applied on the tissue, which is mechanically transduced into the cells [25]. 
Gases in ultrasound fields also behave highly non-linearly.  As ultrasound passes through a 
liquid medium, the local pressure is a sum of the ambient pressure and the acoustic pressure.  When 
the acoustic pressure becomes very negative, the local pressure in the liquid can become negative, 
corresponding to a tensile force on the intermolecular bonds in the liquid.  In response to these 
tensile forces, existing gas bubbles can rapidly expand or new bubbles can be formed within the 
fluid.  As the pressure increases, the sizes can shrink.  At low amplitude pressures, this causes a 
stable oscillation in bubble size that is referred to as stable cavitation.  This can exert some 
mechanical forces on nearby structures.  At higher pressures, rectified diffusion occurs as more 
gas diffuses into the bubble during expansion phase than diffuses out during compression phase.  
At a certain size, the bubble undergoes inertial collapse, a rapid reduction in radius caused by the 
pressure of the surrounding liquid.  This inertial cavitation is highly non-linear and can lead to 
asymmetrical microbubble collapse and jetting [20].   
1.6 Ultrasound Mechanisms of Biological Effects 
This physical understanding of acoustics helps us to characterize how these ultrasound waves 
interact with cells in the body.   Ultrasound bioeffects are a result of thermal or non-thermal 
mechanisms.  Thermal effects occur with continuous wave ultrasound, where acoustic energy is 
deposited through attenuation in the focal area, temperatures can reach 80 degrees and lead to 
coagulative necrosis.  Precisely shaped ultrasound waveforms can lead to sharp lesion boundaries, 
with separation between lethal and sub-lethal effects that are only a few cells thick.  Non-thermal 
ultrasound effects are seen with pulsed ultrasound and include acoustic cavitation, acoustic 
radiation forces, and acoustic streaming [26].    
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1.6.1 Heating (Thermal Ultrasound) 
Some of the earliest applications of ultrasound used unfocused transducer applied directly 
against the body to generate heat deep within tissue.  This technique is still currently used today 
as a therapy for diseases of painful inflammation such as bursitis of the shoulder or tendonitis.  
Temporarily increasing the temperature of muscles, tendons, and other tissue improves blood flow 
which accelerates healing, enhance drug uptake, and promote pain relief [14].  With larger 
increases in temperature, cells can be subjected to conditions that cause them to suffer from 
hyperthermia, which has been briefly investigated as a cancer therapeutic approach to arrest 
growth.  High intensity focused ultrasound (HIFU) is a non-invasive therapeutic modality used 
clinically for tumor ablation in prostate, breast, liver, pancreas, bone, and brain tumors [10, 26-
29]. By producing local hyperthermia and destructive cavitation [30], HIFU induces cell lysis, 
increases chemotherapeutic uptake [28, 31], and stimulates systemic anti-tumor immune responses 
[29, 32].  However, high intensity (ISPTA >100 W/cm2) and high pressure (>10 MPa) focused 
ultrasound indiscriminately destroys healthy tissue as well as tumors [33, 34].  Consequently, 
safely implementing HIFU often requires costly MRI targeting [35] and is challenging in cancers 
near or invading into critical tissue [26].   
 
1.6.2 Non-Thermal Ultrasound 
Cavitation is used as a therapeutic modality in many different venues of medicine.  High 
Intensity Focused Ultrasound (HIFU) uses sufficiently high-pressure ultrasound that both thermal 
and cavitation effects contribute to the tumor ablation.  However, several medical approaches use 
cavitation exclusively to cause localized effects.  Shockwave lithotripsy involve the administration 
of shockwaves, very high pressure, but single or few cycle pulses of ultrasound that converges on 
a renal calculi.  The stone is then exposed to not only strong pressure gradients, but also cavitation 
vents that erode and shatter the stone [36].  Another such technique is phacoemulsification, where 
the lens of an eye clouded by cataracts can be broken down by localized low frequency high 
pressure ultrasound stimulation that breaks apart tissue at the tip of a surgical instrument [37].  
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Cavitation has also been investigated as a non-invasive tissue ablation technique, called histotripsy, 
where clouds of cavitating bubbles are maintained by a pulses of high intensity ultrasound that can 
mechanically disrupt tissue in a tight spatial focus with an apparatus similar to what is used for 
HIFU [38]. 
There is also a growing number of ultrasound bioeffects that fall under the category of 
mechanical (non-thermal) ultrasound, but whose mechanism of action still remains relatively 
poorly understood.  Ultrasound induces mechanical stress in cells through shear stress and 
stretch/compression distributions near the cellular surface through microstreaming around bubbles. 
[39]  Ultrasound can enhance the passage of drugs through cellular lipid bilayers. [40, 41]  
Metastatic cancer cells have a unique mechanical response to deformation compared to less 
malignant or senescent cells as measured through optical microscopy [42].  Studies show that 
highly metastatic epithelial breast cancer cells have a less dense cytoplasm and more pliable 
cytoskeleton [43].  Breast tumor cells also have differing compositions of fatty acids in their cell 
membranes compared to normal breast tissue [44].  Low intensity ultrasound may have a 
selectively strong effect on highly metastatic cancer cells [45].  Chemotherapy is complicated by 
non-specific chemotherapeutic agents and high interstitial pressure inside tumors due to poor 
vascularity and lymphatic drainage that prevents drug uptake.  Ultrasound insonation, particularly 
in combination with microbubble contrast agents, can enhance the permeability of these areas to 
chemotherapy [46].  A study shows that ultrasound alone, without contrast agents, can also 
enhance uptake of the chemotherapeutic adriamycin in U937 suspension cell models [47].  In vivo 
studies suggest that ultrasound can enhance chemotherapeutic tumor control possibly through 
distribution of injected chemotherapeutic agents into poorly vascularized regions of a fibrosarcoma 
[48].  This technique was also shown to allow for lower doses of chemotherapeutic agents and still 
maintain localized chemotherapeutic effects, as demonstrated with low dose scutellarin therapy 
efficacy on human tongue cancer carcinoma xenograft when coupled with low intensity ultrasound 
[49].  
Several approaches aim to increase ultrasound’s specificity.  Molecularly targeted contrast 
agents, such as microbubbles [50, 51] locally amplify ultrasound’s disruptive effects, but are 
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challenging to deploy in tumors due to the agents’ poor extravasation [52].  An alternative 
approach involves low intensity pulsed ultrasound (LIPUS).  Low intensity (ISPTA <5 W/cm2) and 
low frequency (<1 MHz) pulsed ultrasound, as defined in [53], produces mechanical effects 
without hyperthermia, resulting in neurostimulation [54], chemotherapy uptake [46], and bone 
repair [46, 55, 56].  However, its ability to selectively ablate cancer cells has not been studied, and 
its mechanisms of action are not fully understood [57-59]. 
 
1.7 Thesis Outline 
This thesis describes my research at Caltech investigating how modifications of ultrasound 
waveforms can lead to disparate ultrasound effects.  Throughout my graduate studies, I have been 
involved in a variety of project using different ultrasound parameters optimized to generate distinct 
physical responses in biological tissue.   
Chapter 2 describes the theory of oncotripsy that was originally conceived of by Stephanie 
Heyden and my attempts to formulate the theory as a set of testable predictions that can be 
investigated.  Chapter 3 describes the experimental results of those testable predictions as well as 
an investigation into the mechanism of how low intensity pulsed ultrasound can cause cancer-cell 
selective cytodisruption.  Chapter 4 describes the refinements to the oncotripsy theory run by Erika 
Figueroa based on the experimental results and the implications for future research of the 
oncotripsy theory and its potential clinical application.  In Chapter 5, I also describe my 
involvement in other projects as a primer for the discussion of how alternative ultrasound 
waveforms can lead to alternative physical effects in biological tissue.   
  
15 
 
C h a p t e r  2   
 
THEORETICAL FRAMEWORK OF ONCOTRIPSY 
2.1 Introduction 
In this chapter, I discuss the theoretical framework behind the oncotripsy theory.  The 
oncotripsy theory suggests that specifically tailored waveforms of ultrasound can selectively 
damage cancer cells by taking advantage of mechanical differences in their cellular structure that 
distinguishes them from healthy cells.  Erika Figueroa and Stephanie Heyden performed the 
research work included in this chapter, and I was honored to have the opportunity to assist as we 
converged the experimental and theoretical work on this project.  I will begin by describing the 
clinical need for such as cancer selective ablation technique and introducing oncotripsy.  This will 
include a literature review of the various mechanical distinctions between healthy cells and 
cancerous cells and their implications for responding to ultrasound stimulation.  Next, I will 
summarize the theoretical models that have been developed to model the cellular response to 
ultrasound by Heyden and Figueroa, with particular consideration to their implications for cancer 
therapy.  Last I will introduce describe how an ultrasound waveform can be modified in order to 
take advantage of the oncotripsy effect. 
2.2 Oncotripsy as a Inherently Selective Ablation Approach 
 The oncotripsy theory suggests that cell’s mechanical response to ultrasound is highly 
dependent on their mechanical properties.  As such, the biomechanical differences between 
cancerous and healthy cell types cause these cells to have different responses to ultrasound, 
allowing selective ablation of cancer cells with targeted ultrasound waveforms. By stimulating a 
cancer cell using ultrasound at a frequency it is sensitive, the theory predicts that cancer cells will 
undergo more rapid and high amplitude oscillation that lead to cell lysis whereas a healthy cell 
exposed to the same ultrasound parameters will remain unscathed. 
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There is ample evidence in biomechanical literature that a mechanical difference exists 
between cancer cell and healthy cell sub-populations.  Cancer therapy approaches function by 
targeting the most rapidly dividing cancer cells, as these are the most problematic cells that can 
lead to disease prevention, metastasis, and other negative seuqelae.  By nature of being actively 
dividing, these cells are also likely to have several distinguishing biomechanical properties that 
may be exploited by an oncotirpsy therapy.  For example, atomic force microscopy measurements 
have suggested that cancer cells may have a more loosely organized cytoskeletal structure which 
corresponds to decreased cytoskeletal stiffness and altered cellular morphology [60-62].  Cells that 
are in the process of dividing will have more DNA content which is unpacked [63] thus influencing 
the mechanical proeprties of the nucleus.  The increased cellular activity is also associated with an 
increase in the size of the nucleoli of cancer cells [64].  Magnetic resonance elastrography 
performed on the liver have demonstrated distinct changes in viscoelastic properties in the cellular 
microenvironment associated with hepatic tumors [65].  In fact, the mechanical properties of 
cancer cells are sufficiently distinct from those of healthy cells that their deviation as measured 
through micro-pipette aspiration can be used as a metric of a cancer’s metastatic potential [66, 67].  
Overall, cancer cells’ altered cellular/nuclear morphology, DNA content, nuclear-nucleolar 
volume ratios, cytoskeletal stiffness, and viscoelastic properties [60, 62, 65, 68] imply that they 
may be considered a mechanically distinct subpopulation from healthy cells, at least in the same 
tissue structural context.   
The theory implies that a new paradigm of achieving cancer selectivity in therapy is 
possible.  Rather than relying on positional information that distinguishes cells in a tumor from 
healthy tissue or relying on unique molecular targets that are expressed only by cancer cells, 
oncotripsy suggests that it possible to target cancer cells for disruption based on their inherent 
mechanical properties.  This has significant clinical implications.  For example, oncotripsy 
theoretically does not require tumor tracking or the enforcement of therapeutic margins.  By taking 
advantage of its cancer-cell selective mechanism, an oncotripsy system can administer therapy to 
an entire organ and only disrupt the invading cancer cells.  This provides clinicians with a powerful 
and novel therapeutic technique to locally administer targeted cancer therapy without harming 
healthy tissue.   Many of the most therapeutically challenging cancers involve a solid tumor mass 
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with poorly defined borders and invasion into healthy tissue [6, 7].  While HIFU may be unable to 
safely ablate these tumors, oncotripsy’s mechanism may be specifically suited to targeting these 
invading cells.   
Cancers with tissues that differ in mechanical properties of stiffness or structure from 
surrounding healthy tissue may be candidates for oncotripsy therapy.  The treatment of 
glioblastoma multiforme (GBM), the most common primary brain tumor in adults, is a massive 
challenge in neuro-oncology due to the difficulty of establishing effective surgical margins in brain 
tissue [26, 69, 70].  However, the shear elastic moduli is substantially different between normal 
brain tissue and glioma tissues [68].  This contrast in mechanical properties between cancerous 
and non-cancerous cells suggests that oncotripsy may be a therapy to noninvasively destroy GBM.  
Similar applications for oncotripsy can be observed in liver and breast cancer.  The liver is the 
second most common site for tumor metastases and the site of hepatocellular carcinoma (HCC), 
the fifth most common malignancy [71].  Current standard of care is surgical resection or 
transplantation [72] with ablation therapies used as a recourse.  However, common liver metastases 
and HCC have a significantly different elastic moduli than normal liver parenchyma [65], making 
them an ideal potential candidate for oncotripsy therapy.  Breast cancer is the leading cause of 
death among solid tumors in women, the most lethal phenotypes are highly invasive [61], and 
similar evidence exists of a cellular mechanical property mismatch between normal and metastatic 
cancer breast cells [73] suggesting an application for oncotripsy.  Oncotripsy could also be 
effective at targeting hematological malignancies such as leukemia or lymphoma, or even 
circulating tumor cells, cancer cells that have hematogenously spread from primary tumor sites.  
Metastasis is a major cause of morbidity and mortality in patients suffering from cancer [63].  An 
oncotripsy system focusing over a major vein could disrupt circulating tumor cells before they 
have a chance to metastasize.  
2.3 Transient Response Simulations Oncotripsy (Heyden) 
Dr. Stephanie Heyden, from Dr. Michael Ortiz’s solid mechanics laboratory at Caltech, 
posited the initial formulation of the oncotripsy theory that a cell’s mechanical response to 
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ultrasound excitation may be frequency-dependent due to that cell’s unique mechanical properties.  
This section will summarize the work and include figures from her published work [74].  They 
explored this theory by developing a geometric finite element model of a cell that allowed 
frequency-domain and time-domain analysis of excitation with ultrasound stimulation.  The 
structural and physical properties of the simulation were populated from literature analyses of 
hepatocellular carcinoma cancer cells and healthy liver hepatocytes.  This model included several 
simplifying assumptions, including neglecting the viscosity of the cells and the biological 
heterogeneity of mechanical properties present within each of the studied subpopulations.  The 
cell modeled in this finite element model was an idealized set of three nested spheres, 
corresponding to the cytoplasm, nucleus, and nucleolus.  This model also included elements that 
correspond to the spaces between these interfaces: the extracellular matrix, the cytoplasm, the 
nucleoplasm as shown in Figure 2-1.  This preliminary numerical study used a Mooney-Rivlin-
type strain energy density study.  A full description of the computational methods and mechanical 
laws used to develop this model are beyond the scope of this dissertation, however its conclusions 
were key in informing our approach to this project.   
 
Figure 2-1 | Finite Element Mesh for Transient Oncotripsy Theory 
The finite element model used in the transient response formulation of the oncotripsy theory as 
formulated by Stefanie Heyden incorporated three nested spheres that represent the plasma 
membrane, the nuclear membrane, and the nucleolus, as well as the extra-cellular space, the 
cytoplasm, and the nucleoplasm.  Reproduced from [74] 
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Frequency-domain analysis revealed that the cellular model exhibited eigenfrequencies at 
which the cell model underwent resonant oscillation with the ultrasound stimulation.  Moreover, a 
spectral gap existed between the eigenfrequencies of the healthy and cancer cell models.   This 
suggested that an ultrasound frequency may exist at which the cancer cell undergoes a resonant 
response and oscillates very efficiently while healthy cells do not undergo as vigorous an 
oscillation.  In other words, this analysis suggests a differential response between healthy and 
cancer cell types in response to specific waveforms of ultrasound. 
 
Figure 2-2 | Lowest, non-rigid-body eigenfrequencies versus cell cancerous potential 
The first non-rigid body eigenfrequency for each cell model investigated through frequency-
domain analysis of the finite element model analysis.  The x-axis represents cancerous potential, 
which is a linear scaling of the physical properties of the cell model to be that of the noncancerous 
hepatocyte to the cancerous hepatocellular carcinoma cell based on literature review.  Variance in 
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the ratio between nuclear volume to cytoplasmic volume (“n/c”) are also represented in the plot.  
This figure demonstrates a clear “spectral gap” between the cancerous and healthy cells resonant 
frequencies based on mechanical properties.  Reproduced from [74] 
 
This same model was used for time domain analysis which provided further insight into 
how this technique could be adopted for targeted cytodisruption based upon frequency and timing 
of ultrasound stimulation.  The simulation demonstrated that the elements of the cell models had 
a growing oscillation in response to ultrasound stimulation.  The growth rates of these oscillations 
were highly dependent on frequency of ultrasound stimulation and distinct for the cancer and 
healthy models.   
 
Figure 2-3 | Time Domain Simulation of Cellular Oscillation at Two Different Frequencies 
Maximum element oscillation of cell model over time for two different resonant frequencies.  This 
figure demonstrates that the oscillation growth rates of cancerous and healthy cells are distinct and 
frequency dependent.  Reproduced from [74] 
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 By assuming a threshold of oscillation amplitude above which cell death will occur, 
ultrasound frequencies that would achieve the desired outcome of cancer cell disruption while 
sparing healthy cells could be identified by comparing oscillation growth rates.  In Figure 2-3, the 
plot on the right demonstrates a frequency of stimulation where the oscillation in the cancer cell 
model grows rapidly, while the healthy cell has a muted response.   
 
Figure 2-4 | Transient response of cancer cell and healthy simulated cell to ultrasound 
stimulation 
The simulated transient response of the finite element model of a cancerous cell (top) and a healthy 
cell (bottom) at a target frequency.  Note that the Probenius norm of first Piola-Kirschoff stress 
tensor experienced by the cancer cell is more pronounced than that of the healthy cell.  Reproduced 
from [74] 
 
 This computational study established the oncotripsy theory, that cells have resonant 
responses to ultrasound stimulation and the mechanical differences between cancerous and healthy 
cells may allow for an element of selectivity in ultrasound ablation by selecting a resonant 
frequency.  This theory had two important implications for selecting the ultrasound ablation 
22 
 
waveform.  First, the frequency dependence suggests that the signal frequency of ultrasound must 
be carefully selected to induce rapid oscillation growth in the cancer cell to lead to preferential 
lysis.  Second, the duration of the ultrasound pulse must be also carefully controlled.  If sufficiently 
long pulses were used, the oscillation in both the cancerous and healthy cells would both develop 
to lethal levels.  As such, the computational model as described calls for both control of frequency 
and the ultrasound pulsing.    
2.4 Modification of Low Intensity Pulsed Ultrasound Waveform for Oncotripsy Effects 
The implications of this research are that oncotripsy predicts that cells have an inherent 
mechanical response to the pressure waves of ultrasound, independent of thermal effects or bulk 
tissue effects.  Furthermore, cancer cells and healthy cells are predicted to have a frequency-
dependent resonant response to the ultrasound stimulation.  Finally, the damage that is produced 
by ultrasound is highly dependent on the temporal pattern with which ultrasound is applied.  From 
this, we can intuit that to achieve the oncotripsy effect experimentally, we must stimulate our cell 
model with ultrasound of a pulsed single-frequency sinusoidal waveform.  This waveform gives 
us the capability to control the temporal pattern of ultrasound stimulation while administering the 
single-frequency pressure waves necessary to induce oncotripsy.   A pulsed sinusoidal waveform 
for the ultrasound signal has five degrees of freedom that completely define the waveform.  
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Figure 2-5 | Pulsed Sinusoidal Waveform Degrees of Freedom 
Pulsed single-frequency sinusoidal waveforms have 5 degrees of freedom and allow for sufficient 
control of an ultrasound waveform to produce an oncotripsy effect in cells.  This graphic 
demonstrates the change in acoustic pressure over time in this waveform.  1) Frequency – the 
number of acoustic pressure cycles per second throughout the pulse of ultrasound as being applied.  
In ultrasound, frequency is generally in units of MHz.  2) Peak Negative Pressure – the largest 
negative acoustic pressure, caused within one cycle of ultrasound measured.  In this sinusoidal 
signal, the peak negative pressure is equivalent to half the peak-to-peak pressure.  3) Pulse 
Duration - the length in time of each ultrasound pulse train, measured in milliseconds for 
ultrasound.  4) Duty Cycle –the percentage of total time that the ultrasound is active.  5) Exposure 
Duration – defines the total time that the pulsed ultrasound signal is repeating. 
 
In order to achieve the non-thermal ultrasound waveform required to mechanically 
stimulate the cells to achieve the oncotripsy effect, certain constraints must be placed on the pulsed 
sinusoidal waveform.  To avoid heating, the ultrasound intensity must be kept below a specific 
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value.  The term “low intensity pulsed ultrasound” specifically refers to ultrasound with a spatial-
peak-temporal-average intensity (ISPTA) of <5 W/cm2.  This benchmark value provides some 
guidance into the waveform that we should select to avoid thermal effects from dominating the 
desired mechanical effect of oncotripsy.  The ISPTA can be modified by lowering the acoustic 
pressure OR by modifying the duty cycle, as represented in Figure 2-6.   
 
Figure 2-6 | Relationship between Acoustic Pressure and Intensity in Focused Ultrasound 
Beams 
The acoustic intensity of focused pulsed ultrasound waves can be represented through many 
metrics.  Throughout this dissertation, we will be referring to the spatial-peak, temporal-average 
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intensity (ISPTA) as an important metric for representing the heating generated by ultrasound. 
Reproduced from [53] 
 
ISPTA can also be calculated given the following equation [24], where p(t) is the acoustic 
pressure, Z0 is the characteristic impedance, which in tissue can be approximated as 1.5e6 kg m-2 
s-1, and PRF is the pulse repetition frequency: 
𝐼𝑆𝑃𝑇𝐴 = 𝑃𝑅𝐹 ∗ ∫
𝑝2(𝑡)
𝑍0
𝑑𝑡
𝑜𝑛𝑒 𝑝𝑢𝑙𝑠𝑒
 
For our pulsed single frequency sinusoidal signal, this can be simplified as follows where upulsed is 
a gating function that is 1 when the ultrasound is active, and 0 during the ultrasound rest period: 
𝑝𝑠𝑖𝑛𝑢𝑠(𝑡) = 𝑢𝑝𝑢𝑙𝑠𝑒𝑑(𝑡) ∗ 𝑃𝑁𝑃 ∗ sin (𝑘 ∗ 𝑡) 
𝐼𝑆𝑃𝑇𝐴 =
𝑃𝑁𝑃2
2
∗
𝐷𝐶
𝑍0
 
As such, we can arrive at a parameter space of pressures and duty cycles that would not correspond 
to significant heating, assuming that the heating within one pulse is insignificant.  
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Figure 2-7 | Spatial-Peak Temporal-Average Intensity of Ultrasound 
This figure demonstrates that the acoustic intensity of a pulsed ultrasound signal depends on both 
its duty cycle and peak negative pressure 
 
Moreover, we aim to avoid vapor cavitation, a highly non-linear process where the peak 
negative pressure enables bubble nucleation and inertial cavitation, as discussed in Chapter 1.  
Cavitation is a result of a sustained negative pressure applied to the liquid medium, where the 
tension on the water promotes gas bubble formation.  As such, the chance of cavitation is increased 
with high acoustic pressure (with resultant high peak-negative-pressure) ultrasound applied at a 
low signal frequency.  The “mechanical index” [75] is a term used to quantify propensity to 
cavitation, it is calculated as: 
𝑀𝐼 =
(𝑃𝑒𝑎𝑘 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝑖𝑛 𝑀𝑃𝑎)
√𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑖𝑛 𝑀𝐻𝑧
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The lower the mechanical index, the lower the likelihood of cavitation.  An FDA safety standard 
of MI = 1.9 has been set as an upper limit for diagnostic imaging without contrast agents.  To avoid 
cavitation the pressure and frequency must be controlled for as represented in Figure 2-8. 
 
Figure 2-8 | Mechanical Index 
The peak negative pressure corresponding to various mechanical indices at different frequencies 
of stimulation.  Lower mechanical indices reduce the chance of cavitation, with an FDA safety 
limit for diagnostic ultrasound at MI = 1.9. 
 
  So by setting boundary conditions that prevent the non-linear effects of heating and 
cavitation from taking place, we have begun to define the parameters space that we can use to 
investigate the oncotripsy effect.  Next we can look at the parameters suggested by the 
computational study.  These numbers should be taken with a grain of salt as they come from a 
computational model with certain necessary simplifying assumptions, however, they offer a point 
of reference.  The paper suggests that “carefully tuned ultrasound pulses in the frequency range of 
80 kHz, duration in the range of 70 μs and [spatial peak temporal peak acoustic intensity] in the 
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range of 0.8 W/cm2” could induce the oncotripsy effect [74].  An ISPTP of 0.8 W/cm2 corresponds 
to a peak negative pressure of 0.15 MPa.   
In terms of frequency, the computational theory of oncotripsy suggests a very low 
frequency of 80 kHz is ideal in inducing cytodisruption.  There is a technical challenge in 
producing focused ultrasound beams with frequencies that low.  This frequency can be compared 
to a literature review of ultrasound frequencies that have been demonstrated to show ultrasound 
bioeffects without heating or cavitation.  A number of studies specifically referencing mechanical 
and non-thermal low-intensity ultrasound tend to use lower frequency (<1 MHz) pulsed ultrasound.  
These studies reference that this form of ultrasound produces mechanical effects without 
hyperthermia, resulting in neurostimulation [54], chemotherapy uptake [46], and bone repair [46, 
55, 56].  However, its mechanisms of action are not fully understood [57-59].  Since low frequency, 
low-intensity ultrasound has ben documented to produce bioeffects, though the mechanism is 
unknown, this would seem to be an adequate parameter space to test to investigate the oncotripsy 
theory.  If we consider technical limitations, that make it challenging to focus ultrasound generated 
at signal frequencies of less than 0.2 MHz, we have arrived at a window of frequencies to evaluate 
for the oncotripsy effect.  From Figure 2-8, in order to achieve a mechanical index of <1.9 with a 
signal frequency of 0.2 MHz, we must keep the peak negative pressure of our acoustic signal at at 
no more than 0.7 MPa.  From Figure 2-7, in order to achieve a ISPTA < 5 W/cm2 with a peak negative 
pressure of 0.7 MPa, we need a duty cycle of < 25%.  For the purposes of ensuring minimal thermal 
build-up throughout the experiment, and because it is a common experimental convention with 
pulsed ultrasound, we will select a duty cycle of 10%.  Exposure duration will be selected to be 2 
minutes, from experimental convention and to allow for high throughput analyses of multiple 
different ultrasound waveforms. 
The remaining parameter that has not been addressed that is crucially important for the 
oncotripsy theory is the pulse duration.  The oncotripsy theory suggests that cells exposed to 
mechanical ultrasound for sufficiently long pulse durations will ultimately be disrupted.  The 
cancer selectivity of oncotripsy arises from the fact that, at specific target frequencies, the critical 
pulse duration to destroy cancer cells is significantly lower than the pulse duration to destroy 
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healthy cells.  Using the upper bound of signal frequency from literature review of 1 MHz, a one 
cycle pulse would correspond to a pulse duration of 1 μs.  The computational theory suggests that 
pulse durations of 70 μs could induce cytodisruption, so we can consider that parameter.  On the 
upper bound, for the purposes of this dissertation we suggest that 100 ms pulses are an arbitrary 
cut-off, above which the heating within one pulse cannot be discounted.   From a literature review, 
the pulse duration of pulsed ultrasound used for imaging generally corresponds to less than 10 
cycles, or 10 μs assuming a 1 MHz signal.  Implementations of LIPUS that have incurred bioeffects 
tend to have pulse durations somewhere within the millisecond range.  As such, we have placed 
limits on some of the key degrees of freedom for the ultrasound waveform, see Table 2-1.  In 
Chapter 3, we will describe the experimental validation of oncotripsy and investigation of the 
effect of this waveform on an in vitro cell model. 
 Selected Range to 
Investigate 
Reasons 
Frequency 0.2 MHz – 1 MHz 0.2 MHz – technical limitations in focusing 
low frequency  
1 MHz – literature review of a variety of 
unexplained bio-effects for low intensity, low 
frequency ultrasound 
Peak Negative Pressure < 0.7 MPa Necessary to maintain MI<1.9 at 0.2 MHz 
Duty Cycle 0.1 Needed to be below 0.25 to maintain ISPTA < 5 
W/cm2.  Lowered to 0.1 for increased thermal 
safety margin 
Exposure Duration 2 minutes Experimental convention to allow for high-
throughput experiments  
Pulse Duration 10 μs – 100 ms Diagnostic ultrasound (10 μs) and 100 ms to 
prevent thermal effects  
 
Table 2-1 | Waveform Parameters Suggested for Oncotripsy Effect 
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C h a p t e r  3   
 
LIPUS CANCER-SELECTIVE ABLATION OF ONCOTRIPSY 
3.1 Introduction 
In this chapter, I describe the experimental investigation used to test the oncotripsy theory 
and further investigate the mechanism of low intensity pulsed ultrasound (LIPUS) cytodisruption 
in an in vitro suspension cell model.  First, I describe an experiment where we swept various 
parameters of the pulsed sinusoidal ultrasound waveform and evaluated the response of target 
cancer cell and off-target healthy cell subpopulation.  Next, I include the mechanistic analysis of 
the ultrasound physical processes in the observed cancer cell cytodisruption.  Finally, I conclude 
with a proposed unified theory that connects experimental findings of this investigation of LIPUS 
with the protested oncotripsy theory.  I was the project lead on designing and performing these 
experiments, and the results are published in Applied Physics Letters [76]. 
3.2 Experimental Support of Oncotripsy Theory 
3.2.1 Approach 
 For the purposes of the initial investigation into the oncotripsy model, we elected to 
insonate cells in suspension.  This is a well-established method of applying ultrasound to cells that 
streamlines experimental design and allows for high-throughput experiments.  Moreover, 
suspension cells represent a simple mechanical model, with each cell relatively mechanically 
isolated from their surrounding cells, which would enable simpler computational modeling as we 
refine the computational model for oncotripsy.  Several clinically relevant diseases involve cells 
floating in suspension, namely hematological malignancies such as leukemia [77, 78].  Metastasis, 
the spread of malignant cells throughout blood vessels, also involves cancer cells in suspension 
[79].  The clinical significance of a therapy targeted at solid tumor cells is more pressing, however, 
beginning with suspension cells offers a proof of concept that can be expanded upon in future work.   
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As described in Chapter 2, we predicted that low frequency (<1 MHz) pulsed ultrasound 
with an ISPTA < 5 W/cm2 and a mechanical index of < 1.9 could potential incur a cancer-selective 
effect as predicted with the oncotripsy theory.  The oncotripsy theory makes specific testable 
predictions that distinguish it from other potential theories for ultrasound cytodisruption.  These 
predictions are: 1) frequency-dependence of ultrasound cytodisruption, with stronger disruption 
taking place a cell’s resonant frequency, 2) cyto-disruption is a result of a growth in mechanical 
oscillations in cell membranes, as such, a minimum pulse length is required.  This implies that 
non-monotonically frequency dependent and pulse-duration dependent cytodisruption that also 
had distinct effects on healthy and cancer cells would be supportive evidence of the oncotripsy 
theory.  To perform these tests, we needed to isolate the effect of modifying frequency and pulse 
duration during the ultrasound trials. 
3.2.1 Results 
To test the hypothesis that LIPUS can selectively ablate cancer cells, we applied LIPUS to 
suspensions of human K562 and U937 cancer lines and primary T cells isolated from human 
peripheral blood mononuclear cells (PBMC), chosen as representative malignant and healthy cell 
types. Cell suspensions were placed in acoustically transparent-bottomed 24-well plates and 
insonated with a focused ultrasound transducer positioned in a water bath below (Figure 3-1a).  
First, we performed a pressure sweep to determine the pressure of ultrasound that corresponded to 
a cytodisruptive effect.  We used pulsed ultrasound (10% duty cycle) with peak negative pressure 
(PNP) <1.2 MPa that corresponded to an ISPTA <5 W/cm2. We confirmed that 60 seconds LIPUS 
at 0.67 MHz, 20ms pulse duration (PD) induced significant and irreversible cytodisruption of K562 
cells at PNP > 0.6 MPa, as measured with ethidium homodimer-1 (Ethd-1) uptake (Figure 3-1b).  
Heating was always <1°C (Figure 3-7).  For further experiments, we selected 0.7 MPa PNP, which 
induced moderate cytodisruption.  This pressure corresponds with a 1.63 W/cm2 ISPTA and 16.3 
W/cm2 ISPTP at the 10% duty cycle.  At the lowest frequency tested in this study, 0.3 MHz, this 
corresponds to a mechanical index of 1.3, which is beneath the FDA safety limit of 1.9 [53].  The 
lack of heating and the low mechanical index suggests that the ultrasound applied remains within 
the realm of LIPUS. 
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 To test different pulsing patterns, PD and pulse repetition frequency were varied 
simultaneously to maintain a constant duty cycle (Fig 1c).  This resulted in the application of the 
same total acoustic energy by each ultrasound waveform, allowing comparisons across frequencies 
and pulse durations. We swept PD from 2-40ms with each of the 0.3, 0.5, and 0.67 MHz 
transducers (Figure 3-1d). We observed that cytodisruption was highly dependent on frequency, 
PD, and cell type. 20ms PD and 0.5 MHz maximized the selectivity with near complete 
cytodisruption for K562 and U937 and >80% survival for T cells (Figure 3-1e).  We found that 
cytodisruption increases with longer PD, despite the same total energy applied.  Next, we assessed 
a broader panel of cell types at 0.5 MHz, using cancer cells in co-culture with PBMC (Table 3-1).  
The cancer cell models showed significantly more cytodisruption than subpopulations within 
PBMC at >10ms PD.  (Figure 3-1f).  RBCs exhibited virtually no disruption, as measured by 
hemoglobin leakage, under any condition.  
 
4T1 Mouse Cell 
Line 
Mammary Gland, Epithelial 
(human breast cancer) 
CT26 Colon, Fibroblast (Carcinoma) 
MCF7 
Human Cell 
Line 
Mammary Gland, Epithelial 
(adenocarcinoma) 
SK-BR-3 
MDA-
MB-231 
CD4 Human 
Primary Cells, 
Peripheral 
Blood Cells 
CD3+, CD4+ 
CD8 CD3+, CD8+ 
B CD3-, CD19+ 
NK CD3-, CD19-, CD56+ 
RBC 
Bovine 
Primary Cells 
Peripheral Blood Cells 
Table 3-1 | Cell Models Tested 
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Figure 3-1 | Screening reveals ultrasound parameters that induce cancer-cell selective 
cytodisruption. 
a, Schematic of mylar-bottom 24-well plate over water bath containing focused ultrasound 
transducer.  b, K562 cell death (N=3, error bars SEM) in response to 0.67 MHz, 20ms PD, 10% 
duty cycle, 60 seconds, LIPUS at various peak negative pressures (PNP). 0.7 MPa PNP selected 
for future experiments.  c, Diagram depicting constant energy while sweeping PD.  d, 0.3 (N=4), 
0.5 (N=9), 0.67 (N=9) MHz LIPUS induces frequency-, PD-, and cell-dependent cytodisruption.  
e, 0.5 MHz, 20ms PD LIPUS induces significantly less cell death (N=9, p<0.001) on T cells 
compared to either K562 or U937.   f, 0.5 MHz LIPUS induced cancer-selective cell death (N=9) 
in mixed sample of healthy PBMC and cancer models (Table 3-1), measured through cytometry. 
RBC death assessed using hemoglobin release.  Significance indicated as largest p-value from 2-
tailed t-test between each cancer and each healthy cell model.  (* p<0.05, ** p<0.01, *** p<0.001).   
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3.2.1 Discussion 
 The observed cytodisruption from LIPUS was frequency dependent, pulse-duration 
dependent, and cancer-cell selective, as predicted by the oncotripsy theory.   In the in vitro model, 
LIPUS applied at 0.5 MHz with a 20ms PD had the largest therapeutic margin in disrupting a 
diverse panel of cancer cells while leaving healthy blood and immune cells largely intact. 
Cytodisruption at 0.3 MHz was largely ineffective on either cell, while at 0.67 MHz the cancer 
cells were only moderately disrupted.  Our results demonstrate that specific parameters of low 
intensity pulsed ultrasound (LIPUS) can induce cancer cell-selective cytodisruption. While the 
acoustic intensity of the ultrasound is similar to that of diagnostic ultrasound, we found that 
cytodisruption only occurred with pulse durations (PD) of greater than 10 ms, while diagnostic 
ultrasound uses PD of about 10 μs [53].  Simply modifying the ultrasound parameters within the 
previously outlined limits of mechanical ultrasound allowed for cancer-cell selective 
cytodisruption.   
3.3 Cellular Biomolecular and Structural Responses to LIPUS 
3.3.1 Approach  
As we had observed experimental evidence that fit several of the testable predictions of 
oncotripsy, we then endeavored to understand the effects of the ultrasound stimulation on the 
cellular level.  The oncotripsy theory predicts that cellular elements undergo deformation in 
response to ultrasound due to a build-up of resonant oscillation.  When the oscillation reaches a 
certain threshold, the theory suggests that cell death occurs.  In order to investigate this, we 
performed a biochemical assay of a cancer cell model and its response to LIPUS to investigate the 
bio-chemical mechanisms of cell death.  We followed this up with high speed videos to attempt to 
gain insight on the biomechanics involved at the cellular level.  
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3.3.2 LIPUS cytodisruption associated with cytoskeletal damage and activation of apoptotic, 
immunogenic cell death pathways 
To characterize LIPUS cytodisruption’s biomolecular mechanisms, we evaluated CT-26 
cells 2 days after 2-minute treatment with 0.5 MHz, 0.7 MPa LIPUS with flow cytometry. 
At >10ms PD, increased cell death and apoptosis was observed (Figure 3-2a).  Also, cells 
expressing calreticulin, a pro-phagocytic signal [80], increased while proliferative marker Bcl-2 
[81] decreased (Figure 3-2b). The activation of apoptotic and phagocytic pathways may enhance 
LIPUS’ effectiveness as an anti-cancer therapy by promoting anti-tumor immune response.  To 
evaluate LIPUS’ effect on the cytoskeleton, we performed confocal microscopy on CT-26 
immediately after LIPUS. The actin cytoskeleton, stained with phalloidin, is qualitatively and 
quantitatively disrupted after insonation with 30ms PD LIPUS. This agrees with literature that 
states that LIPUS disrupts the cellular cytoskeleton [82, 83].  We demonstrate at 1ms PD LIPUS, 
the cytoskeleton appears unchanged from the negative control (Figure 3-2c).  
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Figure 3-2 | Ultrasound cytodisruption associated with apoptotic and pro-phagocytic pathways. 
a, CT-26 cells assessed 2 days after LIPUS (0.5 MHz, 0.7 MPa 20ms PD, 10% DC, 2 min).  
Fraction of surviving cells and apoptotic cells assessed using flow cytometry Ethd-1 vs Annexin 
V graphs (Fig Sup 2).  X-axis from no ultrasound (∅) to 1-100ms PD.  Significantly increased cell 
death and apoptosis with >10ms PD LIPUS (N=12, error bars SEM). b, Increase in pro-phagocytic 
marker calreticulin (N=12) and decreased survival marker Bcl2 (N=8) but no change in 
proliferation marker Ki67 (N=8) with >20ms PD US.  b, Confocal microscopy of CT-26 cells 
immediately after LIPUS.  30 ms PD LIPUS disrupted actin ring and significantly decreased actin 
stain intensity (N=12). (** p<0.01, *** p<0.001). 
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3.3.3 LIPUS results in translational motion of cells 
To visualize LIPUS’ effect on target cells, we imaged K562 cells in suspension under 
transmitted 2 W laser illumination using an ultra-high speed camera.  Laser light was only applied 
during image acquisition to prevent heating of the cells.  Cells were floating between two 
acoustically transparent films near an acoustic reflector generating standing waves.  We recorded 
video at 5 Mfps starting 100ms after the beginning of insonation.  We observed cells translating 
several microns along the axis of insonation at the ultrasound frequency, but not undergoing large-
scale deformation (Figure 3-3).  This suggests that either that LIPUS’ effect on cell shape are on 
the nanoscale and thus not detectable in this imaging paradigm or involve deformation or 
displacement of sub-cellular organelles relative to the cytoplasm. 
 
Figure 3-3 | High-speed video demonstrates no large-scale cell deformation during ultrasound 
insonation. 
a, Schematic of high frame rate camera setup enabling cellular imaging at 5 Mfps. b, 1d trace over 
time demonstrates translation of cell of ~1 micron after 100ms of 0.67 MHz ultrasound exposure.   
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3.3.4 Discussion 
 This analysis suggests that the LIPUS parameters that induce cytodisruption do so through 
a variety of cellular mechanisms including direct cytodisruption, cytoskeletal damage, and the 
activation of apoptotic pathways.  There is also evidence that pro-phagocytic pathways are 
activated, which are important for the clinical and combined therapy applications of the technology 
and worthy of further study.  The high-speed camera footage provided insight into the mechanical 
forces that are applied onto the cells.   Though this analysis is limited by the resolving power of 
the optics used in this experiment, it does provide an upper bound on the cellular deformations that 
are involved in the response to LIPUS.  The high speed camera video analysis shows cell 
translation, but no detectable (micron-scale) deformation.  Future experiments with enhanced 
resolving power or contrast agents that could provide clearer tracking of sub-cellular components 
could prove very useful in quantifying the cellular deformation in response to ultrasound. 
3.4 Ultrasound Mechanisms Involved in LIPUS Bioeffects 
3.4.1 Approach 
 This experimental data serves as the first investigation of the applicability of the oncotripsy 
theory.  As such, we wished to evaluate other potential explanations for the frequency-, pulse-
duration-, and cell-type- dependency for our LIPUS induced cytodisruption.  To accomplish this, 
and to gain further insight into the acoustic mechanisms for the ultrasound response that we 
observe, we investigate the role that acoustic standing waves, cavitation, and the acoustic medium 
play in transducing LIPUS into cellular effects. 
3.4.2 Standing waves are necessary for LIPUS cytodisruption 
Literature suggests that acoustic standing waves affect the mechanical forces experienced 
by cells [84, 85].  Such waves can result from interference of an incident ultrasound wave with its 
reflection, forming a spatially static pattern of pressure nodes and anti-nodes.  The pressure profile 
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in acoustic 24-well plates revealed a standing wave pattern near the water-air interface. To examine 
whether this plays a role in cytodisruption, we constructed an acoustically transparent cuvette, 
where standing waves could be optionally introduced using a reflector (Figure 3-4a). We found 
that cells insonated in the absence of standing waves (0.67 MHz, 100ms PD) did not show 
significant cytodisruption, while cells treated in the presence of a reflector reproduced the 
cytodisruption observed in the 24-well plate (Figure 3-4b). Doubling the PNP in the reflector-free 
configuration to match the maximal pressure at standing wave anti-nodes did not induce significant 
cytodisruption. This suggests that standing waves are mechanistically required for LIPUS 
cytodisruption. 
Among other effects, acoustic pressure spatial gradients in standing waves give rise to 
acoustic radiation force that pushes cells toward pressure nodes [86]. We tracked the motion of 
fluorescently labeled K562 cells in response to continuous LIPUS in an imaging chamber and 
observed that 0.5 MHz ultrasound in a standing wave configuration propelled cells toward the 
nodes (Figure 3-4c). A 100ms PD was not sufficient for cells to aggregate at nodes, which 
happened after ~1 second under continuous ultrasound. 
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Figure 3-4 | Standing waves required for LIPUS cytodisruptive effect. 
a, Schematics of experimental setups with pressure field measurements.  Standing waves present 
in 24-well plate, but not in acoustic cuvette unless a metal reflector is introduced.  b, 0.67 MHz, 
100ms PD, 0.7 MPa LIPUS does not induce cell death in acoustic cuvette without reflector, even 
when doubling the pressure.  However, when the reflector is added, cell death occurs as observed 
previously.  c, Fluorescence microscopy demonstrates that cells accelerate toward nodes (N) in 
response to continuous 0.5 MHz, 0.7 MPa US.   Upper image is still frame after 5 seconds of 
ultrasound, lower image represents average of y dimension (perpendicular to ultrasound) versus 
time.  Cells achieve aggregation within 1 second. 
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3.4.3 Cell mediated cavitation is required for LIPUS cytodisruption 
Cavitation is a known mechanism for local amplification of acoustic pressure and cell 
killing [87]. To examine its role in LIPUS cytodisruption, we measured the acoustic emissions of 
cells treated with LIPUS in the acoustic cuvette using single-element passive cavitation detector 
orthogonally co-focused with the LIPUS transducer (Figure 3-5a). We measured the signature of 
inertial cavitation (emissions with broad spectral content) and stable cavitation (harmonics of the 
transmitted frequency). As controls, we confirmed that no cavitation was measurable in degassed 
PBS cell buffer, while stable and inertial cavitation were detected from commercial Definity 
microbubbles, which were suspended in the degassed PBS for consistency (Figure 3-5b). 
K562 cells generated both stable and inertial cavitation when exposed to 0.5 MHz, 100ms 
PD LIPUS in the presence of a reflector.  The cavitation magnitude increased during the LIPUS 
pulse with an inflection point around 20ms (Figure 3-5b), a timescale similar to the PD needed 
for cytodisruption. No cavitation was seen without a reflector.  Laser illumination of the cuvette 
revealed bubble formation in a standing wave pattern in response to long-PD ultrasound in the 
presence of the reflector (Figure 3-5d). 
The conditions resulting in LIPUS-induced cavitation in K562 cell suspensions correlate 
with those causing cytodisruption, with both requiring standing-waves and PD >20ms (Figure 
3-5c).  However, cavitation is not sufficient for cytodisruption, since PBMC, which are not 
strongly disrupted by tested LIPUS conditions, nevertheless produced similar amounts of 
cavitation (Figure 3-5c). 
To determine which components of cell suspensions could be responsible for cavitation, 
we measured acoustic signal from LIPUS-exposed solutions of cell-sized 10 μm polystyrene beads 
and liposomes. These liposomes were formed in the lab in degassed conditions to prevent gas core 
formation, and degassed again prior to experiment.  No cavitation was detected from the beads. 
42 
 
However, degassed liposomes did produce cavitation, suggesting that cell’s lipid contents may 
have a role in promoting cavitation (Figure 3-5c).  
Finally, to confirm that cavitation is necessary for cytodisruption, we suppressed cavitation 
by placing the cell solution within an acoustically transparent pressure-chamber comprising a 
plastic pipette bulb and applying hydrostatic pressure by connecting the sealed chamber to a 
compressed air source pressurized to 400 kPa above ambient atmospheric pressure (Figure 3-5e).  
Elevating the  hydrostatic pressure within the bulb created an environment where cavitation was 
suppressed by decreasing the absolute magnitude of the peak negative pressure induced by 
ultrasound insonation [88-90].  With the bulb pressurized to 400 kPa above ambient pressure, there 
was an almost complete reduction of cytodisruption of K562 cells in the chamber by 100ms PD 
LIPUS.  This confirms that cavitation is mechanistically necessary. 
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Figure 3-5 | Cell-mediated cavitation is mechanistically necessary for cytodisruption. 
a, Schematic of passive cavitation detection setup using 10 MHz transducer orthogonally 
positioned to FUS transducer.  b) Spectrogram of scattered signal from 100ms pulse of 0.5 MHz 
ultrasound transducer.  Broadband signal of cavitation demonstrated with Definity positive control.  
No cavitation in PBS, however cavitation present in K562 suspensions only with reflector. c) 
Cavitation energy (∫ P2 dt) partially correlates with cytodisruption.  Significant cavitation 
(compared to “No US”, ** p<0.01, *** p<0.001) observed with Definity, with K562 / PBMC with 
reflector (RF) and >20ms PD, and with liposomes with RF and 100ms PD. Note: PBMC cells 
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induce cavitation, though they are resistant to LIPUS cyto-disruption.  d, 100ms PD LIPUS with 
reflector induces cavitation bubbles formed in standing wave pattern in K562 sample.  e, 
Schematic of pipet bulb pressurized to 400 kPa to form pressure chamber. At over-pressure, which 
suppresses cavitation, LIPUS cytodisruption is suppressed. 
 
3.4.4 LIPUS cytodisruption attenuated in solid media 
To investigate whether LIPUS cytodisruption occurs in cells embedded in solid media, we 
suspended K562 cells in agarose and acrylamide gels.  We placed these gels in our acoustic cuvette 
with the reflector to generate standing waves (Figure 3-6a) and exposed them to ultrasound.  Cell 
death in the LIPUS treated gels was assessed using Ethd-1 fluorescence and compared to untreated 
control gels (Figure 3-6b).  While statistically significant cytodisruption in agarose gels was 
observed, it was greatly attenuated compared to liquid suspensions (Figure 3-6c).  This suggests 
that either the mechanical rigidity or the translational motion restriction imposed by a solid extra-
cellular medium inhibits LIPUS cell killing. 
  
45 
 
 
Figure 3-6 | Cells suspended in gel medium undergo attenuated cytodisruption in response to 
our targeted LIPUS parameters. 
a, Schematic diagram and picture demonstrating 1 cm thick 1% agarose gels containing K562 cells 
and their placement between the 0.5 MHz transducer and the metal reflector.  b, Cytodisruption 
was assessed using ethidium homodimer assessed in gel reader, positive control had injection of 
Triton X-100 in center of gel.  c, Cell death is completely attenuated in acrylamide gels compared 
to free fluid condition.  Cell death is attenuated, but still significant in agarose gels.  Observed 
using ethidium homodimer-1 fluorescence after ultrasound at 0.5 MHz, PD 100 ms. 
 
3.4.5 Discussion 
These experiments revealed that the formation of standing waves and the emergence of 
cavitation were necessary to disrupt cancer cells. However, the presence of cavitation, which was 
seeded by cells and enhanced by standing wave ARF, was not sufficient to guarantee the disruption 
of any particular cell type. This is consistent with our finding that the most significant 
cytodisruption took place at 0.5–0.67 MHz and not 0.3 MHz, despite an expected increase in 
cavitation at lower frequency. This suggests that while cavitation may locally amplify the pressure 
supplied LIPUS, a given cell type’s response to the resulting mechanical stress depends on its 
biophysical properties. This is consistent with the “oncotripsy” theory developed by Ortiz et al [74, 
91], which suggests that cells respond to ultrasound at different resonant frequencies and with 
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different fatigue behavior based on their distinct mechanical properties [92, 93].  Additional studies 
are needed to probe the biophysical underpinnings of this response. 
3.5 Conclusion 
Cancer-selective cytodisruption by LIPUS could fulfill the clinical need for safe non-
invasive tumor ablation, complementing positional or molecular targeting approaches. Based on 
our results in suspension cell models, LIPUS applied within blood vessels could target blood 
cancer or circulating tumor cells [94]. The needed standing waves could be generated by 
engineering the acoustic field of one or more array sources or leveraging endogenous reflective 
surfaces such as bones. In addition, the acoustic field may need to be sufficiently large to enable 
appropriate continuous exposure of cells during flow. In addition, our data indicating that LIPUS-
disrupted cells show markers of apoptotic and immunogenic cell death (ICD) suggest that 
disruption of cancer cells in circulation could stimulate immune responses against solid tumors 
elsewhere and strengthen the effect of conventional chemotherapeutic regimens [95-103].  
Additional work is needed to extend this technology into the solid tumor context. While in our 
experiments cells in hydrogel phantoms responded weakly to LIPUS, this biochemical and 
mechanical context may not accurately represent the solid tumor milieu. In addition, even partial 
killing of solid tumor cells could be effective if it can precipitate an abscopal immune effect.  
Future cell monolayer, 3D culture, and finally in vivo studies are needed to test these hypotheses. 
Emerging protocols for cancer therapy are increasingly using synergistic therapy involving 
chemotherapeutics, immunotherapy, and surgery.  Novel immunotherapy drugs that assist in the 
formation of a systemic anti-neoplastic immune response, such as anti-PD1 or TLR9 agents are 
showing promise in tumor remission and prevention of recurrence [104].  Ultrasound oncotripsy 
has a strong synergistic potential in its capability to selectively increase the membrane 
permeability of target cells.  This can allow for increased uptake of a chemotherapeutic or release 
tumor-specific antigen to induce a systemic anti-cancer immune response.   
In summary, ultrasound oncotripsy could have significant clinical benefits, particularly in 
clinically challenging tumors, where enforcement of therapeutic margins is difficult [70].  
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Combining local surgical resection with regional ultrasound oncotripsy that selectively targets 
cancer cells distributed throughout healthy tissue and enhances systemic chemotherapy and 
immunotherapy could not only remove the bulk tumor, but help address micro-metastasis that lead 
to tumor recurrence.  
3.6 Methods 
3.6.1 High Throughput Ultrasound Experiments 
We developed a high through-put experimental system that allowed for Acoustically 
transparent 2.5 μm mylar film (Chemplex #100) was placed on the bottom of 24-well no-bottom 
plates (Greiner Bio-One #662000-06) that have been painted with a thin film of Sylgard 184 PDMS 
(Fisher Scientific # NC9285739) and heat treated at 60 °C for 24 hours.  The resulting 24 well 
plates are watertight and have acoustically transparent bottoms.  The plates were sterilized and 
loaded with cell samples as required for ultrasound exposure.   
24 well plates were placed on a metal stage such that the mylar film was in contact with a 
water bath.  One of the three available FUS transducers (0.3 MHz: Benthowave BII-7651/300, 0.5 
MHz: Benthowave BII-7651/500, and 0.67 MHz: Precision Acoustics PA717) was attached to a 
metal arm angled 20 degrees from the normal of the water bath.  A Velmex X-Slide motorized 
positioning system allowed the 3d motion of the arm allowing the transducers to be targeted at 
each well individually.  The transducers were aligned using a Precision Acoustics fiber optic 
hydrophone to target the bottom center of well A1 on the 24 well plate.  A MATLAB script 
controlled a signal generator (B&K #4054B) which generated a unique RF signal for each well of 
the plate and the Velmex positioning system.  This signal was then amplified (AR #100A250B) 
and sent to drive the FUS transducers.  The water bath was filled with distilled water that was 
degassed by a water conditioning system (ONDA #AQUAS-10) and heated to 37 degrees Celsius 
prior to experiments.  
Fiber optic thermometry was used to measure the effect of insonation at the highest 
frequency 0.67 MHz and highest pressure 1.2 MPa PNP tested to confirm that no heating would 
48 
 
occur in LIPUS experiments.  Fiber was placed at ultrasound focus within acoustically transparent 
24 well plate and temperature measurements were made for 1 ms and 100 ms pulse duration 
insonations.  (Figure 3-7) 
For the parameter search experiments (Figure 3-1d) K562, U-937, or T cells were spun 
down and carefully resuspended in vacuum degassed PBS containing 2 μM ethidium homodimer-
1 (Ethd-1) at 2 million cells in 2 mL PBS in each well of an acoustic 24 well plate.  On each plate, 
2 wells were loaded with 0.1% Triton X-100 as a positive control (pos) and 2 wells were un-
insonated as a negative control (neg).  Immediately after insonation, cell death for each well was 
estimated as Ethd-1 signal (s) as measured through plate reader as: cell death = (swell – sneg) / (spos 
– sneg). 
For the broad cell panel experiments (Figure 3-1e), 2x106 4T1, CT26, MCF7, SK-BR-3 or 
MDA-MB-231 cancer cells were mixed with 2x106 PBMCs in 2 mL degassed PBS respecitively 
and loaded into each well of an acoustic 24 well plate.  After insonation, 2x104 cells are cultured 
on 96 well plates for 2 days, and resuspended in PBS with 2 μM Ethd-1 prior to analysis with flow 
cytometry.  For immune cell surface marker analysis, single-cell suspensions were stained with 
antibodies in PBS containing 2% fetal bovine serum. Antibodies to CD3(UCHT1), CD4(SK3), 
CD8(RPA-T8), CD19(SJ25-C1), CD33(P67.6) and CD56(5.1H11) were used to gate the CD4 T 
cells, CD8 T cells, B cells, myeloid cells and NK cells respecitively.  Myeloid cells, which are 
largely undifferentiated cells with similar mechanical properties as cancer cells and comprise <1% 
of the PBMC cells, were excluded from analysis.  Cell death for each subpopulation was 
determined from the count of cells that did not uptake Ethd-1 in comparison to untreated control.   
Heparinized bovine red blood cells (Sierra for Medical Science), were diluted to 10% 
hematocrit in degassed PBS, then insonated as described above.  After ultrasound, RBCs were 
centrifuged so that samples of supernatant could be assessed for hemoglobin release (Abcam 
ab234046).  RBC death in resposne to LIPUS calculated as hemoglobin release compared to 
positive control 0.1% Triton X-100 and negative control of no ultrasound. (Figure 3-1e) 
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3.6.2 Analysis of biomolecular pathways of cytodisruption 
For CT26 cell apoptosis and proliferation marker analysis,  2 days after ultrasound 
treatment, CT26 cells were stained with anti-Calreticulin (Abcam) 30 min at room temperture. 
Annexin V binding buffer (Biolegend) was used for Annexin V staining. Fixation and 
permeabiliztion was performed with BD Cytofix/Cytoperm buffers (BD Biosciences) for Ki-67 
and Bcl-2 intracellular antibodies staining.  (Figure 3-2a)  Cell death was determined from the 
count of cells that did not uptake Ethd-1 in comparison to untreated control.  The percentage of 
apoptotic cells reported is the fraction of Annexin V positive and Ethd-1 negative cells measured 
through flow cytometry.  Cell signaling pathway markers Bcl-2 and Ki-67 were the fraction of 
Bcl-2 or Ki-67 stain positive and Aqua (fixable dead cell stain) negative cells.  The pro-phagocytic 
marker calreticulin percentage reported was the fraction of calreticulin stain positive in all cells, 
live or dead.  Flow cytometry gates are shown in Figure 3-8. 
For confocal experiments, CT-26 cells were allowed to settle on PDL-coated 1.5 μm 
coverslips for 1 hour.  Slides were treated with fixable LIVE/DEAD stain (ThermoFisher 
#L34971), fixed in 4% paraformaldehyde and stained with phalloidin (Cayman #20549).  
Coverslips are then mounted with mountant containing DAPI (ThermoFisher #P36971).  Four 
color confocal images were acquired with a 100x oil immersion objective at the Caltech Beckman 
Imaging Facility. (Figure 3-2b)  To quantify, the actin signal intensity was measured on 12 cells 
imaged in each ultrasound treatment condition. 
3.6.3 Investigation of standing waves and acoustic radiation force in cytodisruption 
Pressure measurements performed using the fiber optic hydrophone positioned using the 
Velmex X-Slide.  Color scale pressure maps represent peak negative pressure at each position 
within well or acoustic cuvette.  Acoustic cuvettes were 1 cm x 1 cm 3d printed chambers with 
walls made of mylar film fixed with super glue.  The cuvette was mounted to the bottom of the 
water tank and surrounded by distilled, degassed water.  The center of cuvettes were aligned with 
the FUS transducer focus using fiber optic hydrophone and Velmex positioning system.  A 
3”x3”x0.5” rectangular prism block of aluminum was used as an acoustic reflector and positioned 
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directly opposite from the transducer next to the cuvette (Figure 3-4a).  K562 were loaded into 
the acoustic cuvette at 1 M cells / mL containing 0.2 μM Ethd-1.  A 3d printed imaging chamber 
submersed in a water bath positioned the 0.5 MHz transducer a fixed position from an acoustic 
reflector, such that fluorescent imaging of a compartment containing GFP-labeled K562 at the 
focal point of the transducer could be achieved. Imaging was obtained through a 4x air objective 
(Olympus) (Figure 3-4c).   
3.6.4 Role of cavitation in cytodisruption 
Using the same setup for standing wave experiments, a 10 MHz single element transducer 
(Olympus #U8421024) was positioned orthogonally to the FUS transducer, also aligned using the 
fiber optic hydrophone (Figure 3-5a).  The signal from the single element transducer was captured 
directly by an oscilloscope (Keysight InfiniiVision 3000 X-series) without pre-amplification.  4M 
data points were acquired during the signal transmission period of LIPUS.  Frequency spectral 
analysis was then performed to generate logarithmic spectral graphs of frequency intensity at 
various representative time points during the pulse (Figure 3-5b) and quantification of total signal 
energy (Figure 3-5c).  Samples were loaded into the acoustic cuvette.  Vacuum degassed PBS 
used as negative control.  10 μL of freshly resuspended Definity microbubbles (Lantheus Medical 
Imaging, Inc.) in degassed PBS used as positive control.  Aluminum reflector used as described 
above to introduce standing waves.  K562 or PBMC cells loaded at 1 M cells / mL in degassed 
PBS.  Liposomes were generated from 14.0-18.0 PC Avanti Polar lipid suspended in chloroform 
which was lyophilized to remove chloroform, rehydrated using degassed 300 mOsm sucrose 
solution, sonicated for 10 minutes, heated at 40°C for 10 minutes, then degassed.  Liposomes 
solution resuspended in degassed PBS to approximate lipid concentration in cell samples.  10 μM 
polystyrene beads at 1 M beads / mL also measured.  Cavitation energy assessed in relative units 
by integrating the square of the pressure signal over time (Figure 3-5c).  Image of cavitation 
bubbles taken using camera facing the single element transducer, with plane of laser illumination 
generated from laser light source and 1D diverging lens positioned above the acoustic cuvette 
(Figure 3-5d).  A pressure chamber was constructed by attaching a compressed air line with a 
gauge pressure of 400 kPa onto an acoustically transparent plastic pipet bulb.  Acoustic 
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transmission through the pipet bulb was confirmed using hydrophone measurements.  1 M/mL K-
562 cells loaded in degassed PBS containing 2 μM Ethd-1 into the pipet bulb.  Cavitation from in 
samples loaded into the pipet bulb in place of the acoustic cuvette could be measured as described 
above.  Cell death assessed using Ethd-1 signal (Figure 3-5e). 
3.6.5 Solid model investigation 
Agarose gels were prepared by mixing 2% agarose in vacuum-degassed PBS at 65 °C with 
2 M/mL K562 cells in PBS, adding 2 μM Ethd-1, and poured into 1 cm x 1 cm x 2.5 cm molds.  
Acrylamide gels were prepared as in this reference [105] with a final concentration of 1 M/mL 
K562 and 2 μM Ethd-1.  Gels were insonated in the acoustic cuvette as described above.  Cell 
death was calculated as magnitude of Ethd-1 signal observed at LIPUS focus on gel reader in 
comparison to signal from gels injected with 0.1% Triton X-100 and gels not treated with LIPUS.   
3.6.6 High speed camera visualization of cell deformation 
We assembled a high-speed microscopy setup capable of directly visualizing the effect of 
ultrasound on K562 cells. Our setup used a 2 W 532-nm laser (CNI, MLL-F532-2W) controlled 
by an optical beam shutter (Thorlabs SH05, KSC101). Right angle prism mirrors directed the laser 
light through a water bath and into a sample chamber containing the imaged samples. K562 cells 
were loaded into a custom-made acrylic cartridge containing an inner pocket surrounded by mylar 
film.  A 3d printed holder positioned the cartridge such that the inner pocket was at the focus of 
the 0.5 MHz transducer.  The cells were freely floating between two acoustically transparent films 
near an acoustic reflector that generate standing waves.  A 100x water immersion Plan Fluor 
objective (Olympus) was used to image the target cells.  A series of prism mirrors and converging 
lenses with focal lengths of 200 mm and 50 mm delivered the image into a Shimadzu HPV-X2 
camera, which acquired 256 images over 51.2 µs, at a sampling rate of 5 million frames per second. 
To account for acoustic propagation through water, the camera was externally triggered to begin 
acquisition 100 ms after the start of the ultrasound pulse. A single pulse of 100 ms at 0.5 MHz and 
0.7 MPa PNP was used to insonate the sample in these experiments. 
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3.7 Supplemental Figures 
 
Figure 3-7 | No temperature change induced by LIPUS.   
Assessed temperature change using fiber optic hydrophone system at focus of FUS transducer in 
24-well plate configuration.  LIPUS applied at 0.67 MHz, 1.2 MPa PNP, with 10% duty cycle did 
not induce any appreciable change (<1 °C) in temperature even with 100 ms pulse duration. 
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Figure 3-8 | Flow cytometry gates used for phagocytic, apoptotic analysis 
a, Ethidium homodimer (Ethd-1) vs Annexin V stain generates the following quadrants.  Q4: live 
cells, Q3: live cells undergoing apoptosis, Q2-Q1: dead cells.  b, Ki-67 vs Bcl-2 stains used to 
identify Bcl2+ and Ki-67+ populations.  
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C h a p t e r  4   
 
REFINEMENT OF ONCOTRIPSY THEORY, FUTURE DIRECTIONS 
 
4.1 Introduction 
In this chapter, I will discuss the refinements made to the oncotripsy theory in light of the 
experimental evidence attained as described in Chapter 3.  The new computational model, focusing 
on accumulating cytoskeletal damage and cyclic fatigue, as developed by Erika Figueroa with my 
experimental input, is summarized and its implications for future work in oncotripsy are discussed.  
Finally, this chapter concludes with a description of future directions for the oncotripsy project in 
combined therapy and solid tumor treatments as are being investigated by Dr. Peter Lee’s group 
in City of Hope.  
4.2 Inconsistencies between Transient Response Oncotripsy Model and Experimental Data 
The experimental data did indeed show frequency-dependent and cell-type specific 
cytodisruption in response to low intensity pulsed ultrasound (LIPUS).  However, there were some 
inconsistencies in the predictions from the theoretical model and our experimental results.   
Firstly, the experimental data suggested that the mechanical transduction of the acoustic 
energy into the cell is more complex than was originally conceived in the original oncotripsy 
theory.  Experimental evidence suggested that standing wave conditions and cell-mediated 
cavitation were required for oncotripsy to take effect.  This suggests that there are additional 
mechanisms at play beyond simply the cell’s response to the acoustic pressure waves.  However, 
the frequency-dependency of the ultrasound stimulation does suggest that the oncotripsy 
mechanism of an inherent mechanical response of the cells is still an important part of the pathway 
of LIPUS cytodisruption.  Though this merits further studies, we have developed a hypothesis to 
reconcile our experimental findings.  We hypothesize that standing waves serve to enhance lipid-
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cavitation [106] through cellular aggregation [107] and that the harmonic cavitation acts as a local 
amplifier of the ultrasound signal to induce local cell oscillation at the target frequency.  The final 
chapter of this work includes a more detailed investigation into this theory.  The cell then can 
respond to the acoustic signal as is amplified by the stable cavitation.  This hypothesis is supported 
by the observations that cavitation alone is not sufficient for cytodisruption, as the healthy cells 
exhibited the same cavitation energy as cancer cell suspensions upon insonation, but did not have 
as strong of a response to ultrasound as the cancer cells.  The unique predictions of the oncotripsy 
theory of frequency-dependence, pulse-duration-dependence, and cell-type specificity were still 
observed despite the dependent mechanistic role of cavitation and standing waves.  
Some inconsistencies likely came from the difficulty of obtaining the precise mechanical 
properties to describe the viscous and elastic properties of cells.  The transient response model by 
Heyden was defined using a literature review that cross-referenced multiple measurements of the 
elastic properties of hepatocellular carcinoma cells and compared them with healthy liver 
hepatocytes.  A sensitivity analysis was also performed including measurements from other cancer 
and health cell models that suggested broader applicability among other cells, which is the reason 
that we performed experiments with a different panel of cells during our experimental validation.  
However, mechanical properties that describe an objects response to stress are highly dependent 
on the frequency at which the oscillating stress field is being applied [108].  The measuring 
techniques used generally assessed the cellular response to a static stress, or a dynamic stress 
oscillating in the sub-kHz range, as higher shear rates are challenging to assess [66, 67].  
Unfortunately, it would likely be a massive undertaking to correctly ascertain the appropriate 
mechanical parameters from independent measurements in order to develop an accurate model 
from first principles.  Furthermore, this would not account for the role of cavitation, which may 
act as a local amplifier of ultrasound in a way that is challenging to model.  What is possible, 
however, is to fit the necessary parameters of the computational model in such a way that it 
recapitulates experimental data.  Then such a model can be used to extrapolate the cellular response 
to ultrasound waveforms that were not tested experimentally, offering a guide-post for future 
experimentation and model validation. 
56 
 
We believe that the inconsistencies in the ideal frequency and pressure required to achieve 
an oncotripsy effect are likely due to the errors in the input parameters and could be corrected by 
fitting these parameters of the model with experimental data.  However, one error that is difficult 
to account for is the inconsistency is with the pulse duration required for cytodisruption.  While 
the theory predicts that pulse durations of approximately 100 μs should be sufficient for 
cytodisruption, our experiments suggested that pulse durations of greater than 10 ms were required 
for significant cell death.  With 1 MHz ultrasound, 10 ms corresponds to 10,000 cycles of 
ultrasound.  It is very unlikely that at 10,000 cycles, the cell is still experiencing a transient 
response to ultrasound.  In fact, the oncotripsy computational model suggest that the cell’s 
oscillation has achieved a steady-state condition by that point of ultrasound stimulation.  The 
transient response oncotripsy model, which suggests that cytodisruption occurs when the growth 
rate in cell oscillation occurs faster with cancer cells than healthy cells at target resonant 
frequencies that leads to cancer-selective cytodisruption, thus requires adjustment. 
4.3 Reduced Cytoskeleton Constitutional Model (Figueroa) 
Erica Figueroa, also at Ortiz lab, refined the oncotripsy theory to consolidate the 
predictions from the theory with the experimental results.  This section references heavily from 
her pre-publication on arXiv regarding this discussion [109].  This model idealizes the 
cytoskeleton as a random 3D network consisting of interconnected actin filaments and 
microtubules spanning a rigid and heavy organelles and a rigid oscillating cell membrane.  The 
essential novelty of the model will be the accounting of the competition between damage to the 
filaments under plausible failure scenarios, such as a critical elongation or force, and healing of 
the same filaments after the passages of a certain lag time. Such a competition is a classic example 
of a ‘birth-death’ process in evolutionary dynamics [110].  The experimental observation that 
LIPUS with a pulse duration of 10 ms is required for cytodisruption suggests that a potential model 
for the cellular response to ultrasound is one of cyclic fatigue.  Rather than modeling the cells as a 
structure that fails as soon as deformation increases past a certain threshold, this new model 
considers the cell as a tensegrity structure, with cytoskeletal elements that can accumulate damage 
in response to stress.  The computational tensegrity model consids of a random three-dimensional 
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network of filaments and tubules spanning a rigid and heavy nucleus and a rigid oscillating cell 
membrane.  Critically stressed filaments (in red) are targeted for failure and removed from the 
network (damage), possibly to be reinstated after some lag time (healing).   
The system incorporates a damage variable that represents the proportion of tensegrity 
elements aligned along a certain direction being broken, and thus no longer contributing to 
maintaining cytoskeletal stiffness.  Kinetic coefficients define a “birth” and “death” process of the 
cytoskeletal state that enables modeling of the tensegrity structure that evolves over time in 
response to ultrasound stimulation.  The material parameters used in this simulation were taken 
from literature review, as in the Heyden model, but were also tested and fitted against experimental 
data.  This allowed for the development of a refined finite element model that could describe how 
damage could accumulate with pulsed ultrasound stimulation. 
 
 
Figure 4-1 | Evolution of Cytoskeletal Element Damage during Ultrasound Stimulation 
Mean of the damage of a cancerous cell predicted through finite element tensegrity model in 
response to ultrasound stimulation with pulse duration of 0.1 ms.  Damage accumulates during 
insonation, and then decreases gradually during the healing process.  Reproduced from [109] 
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This model was computationally intensive, so a simplified one-dimensional model with 
isotropic simplifications was developed to allow for longer time-domain simulations.  The reduced 
model generated consistent predictions as the full finite element model.  However, it had the 
benefit that it reduced the cell’s response to ultrasound as purely a function of the interaction 
between a pulsed ultrasound signal and four abstract cell parameters: 
 ω0 – natural frequency of vibration 
 ζ – damping ratio 
 tr – relaxation time for healing 
 qc – critical damage prior to cell death 
 
This model allows sufficiently long simulations to investigate the role of varying pulse 
durations on cell models.  Figure 4-2 demonstrates the strength of the cytoskeletal damage model 
in differentiating the effect of infrequent long pulses versus frequent short pulses.  The model 
demonstrates that long pulses allow the accumulated damage in the cytoskeleton to reach higher 
peaks and accumulate to higher values than repeated shorter pulses.  The presence of periods of 
healing between the pulses, even short periods, prevent the cell damage from achieving its 
maximum potential.  When cell damage reaches a critical damage point qc the cell is considered 
to have died in this reduced model.  
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Figure 4-2 | Cytoskeletal damage evolution with reduced dynamical oncotripsy model 
Mean of the damage of a cancerous cell predicted through reduced oncotripsy model in response 
to ultrasound stimulation with varying pulse durations.  a) 100 ms PD, b) 10 ms PD, c) 1 ms PD, 
d) limit with infinitesimal pulse duration.  Higher levels of cytoskeletal damage are achieved with 
long pulses. Reproduced from [109] 
 
This reduced model allows for simulations of populations of cells with varying mechanical 
properties as represented by the variables above being sampled from normal distributions around 
specified population means.  These simulations allow for the recapitulation of the sigmoidal curves 
of the observed increased cytodisruption with increasing pulse duration, and other experimentally 
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measured values.  This allows for curve fitting from experimental data to enhance the extrapolative 
potential of the model.  The natural frequency of vibration and damping ratio can be determined 
for a cell population by performing a frequency sweep using a high-bandwidth ultrasound 
transducer.  The experiments described in the previous chapter of this work were performed using 
three low-bandwidth transducers, and as such only allowed an assessment of three frequencies.  
Subsequent work using multiple transducers capable of sweeping frequencies could solve for the 
natural frequency and damping ratio of the reduced model of oncotripsy.  The relaxation time and 
critical damage could be calculated using the pulse duration curves as a metric of how cell damage 
varies based on the temporal distribution of the ultrasound stimulation.   A system of cytoskeletal 
damage and healing in response to mechanical stresses preserve the frequency-dependence of the 
original system and offers a mechanistic explanation for the pulse-duration dependence of the 
oncotripsy effect.  A full description of this model is beyond the scope of this dissertation; however, 
its implications provide valuable insight into how cells may respond differently to prolonged 
pulses of ultrasound versus repeated short pulses of ultrasound on a mechanical level.   In her 
thesis, Erika Figueroa describes how the reduced oncotripsy model, when fit with data from 
experiments similar to those that I performed and described in the previous chapter, could be used 
to determine the ideal insonation parameters to achieve selectivity in cytodisruption of cancer cells 
without harming healthy cells. 
4.4 Conclusions 
These refinements to the computational model suggest that oncotripsy theory could serve 
as a valid mechanism for the experimental evidence of frequency and pulse duration-dependent 
cytodisruption.  Further research into the oncotripsy theory should explore the testable predictions 
from the cytoskeletal cyclic fatigue model with newly posed experiments that both investigate the 
mechanism of cytodisruption as well as the effect of additional ultrasound waveforms on wider 
variety of cells in vitro and in suspension.  An exploration of potential experiments that could 
provide further insight into the oncotripsy mechanism and into its applicability in clinically 
relevant contexts is included in Chapter 6 of this thesis.  
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C h a p t e r  5   
 
ALTERNATIVE WAVEFORMS FOR CELLULAR MODIFICATION / 
CONTROL 
 
5.1 Introduction 
 In this chapter, I will describe some of the other work that I have had the opportunity to be 
a part of during my time at Caltech working on research in ultrasound therapeutics.  These are 
included in my dissertation as a demonstration of how ultrasound’s bioeffects are widely varied 
and dependent upon the ultrasound parameters used.  First, I describe work that I did with Avinoam 
Bar-Zion to investigate the cavitation of gas vesicles in response to short pulses of high amplitude 
ultrasound.  Then I describe a work that I did with Mohammad Abedi regarding using high 
intensity focused ultrasound to activate thermally controlled circuits in vivo. 
5.2 Modification of Pulsed Ultrasound Parameters 
The bulk of my thesis work has involved using low intensity pulsed ultrasound (LIPUS) to 
induce selective ablation in cancer cell models through a novel mechanism described as 
“oncotripsy” which involves a frequency-dependent mechanical response of the cell to ultrasound 
stimulation.  However, there are many other parameters spaces that are used to achieve different 
bio-effects.  A waveform optimized to induce cavitation will use much lower frequencies and 
higher pressures than LIPUS.  Pulse durations may be extremely short, as the inertial cavitation 
event occurs only after a few cycles of insonation.  In this chapter, I include a discussion of the 
cavitation waveform used in the gas vesicle cavitation project as a demonstration of this waveform.  
Conversely, a waveform optimized induce thermal effects, would high frequency, high pressure, 
and continuous wave, in order to maximize the power that is attenuated into tissue.  In this chapter, 
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I include a discussion of the ultrasound waveform used in the thermal control project as a 
demonstration of this. 
 
 
Figure 5-1| Ultrasound Waveforms for Different Bioeffects 
Three waveforms discussed in this dissertation: Low intensity pulsed ultrasound (LIPUS) uses 
medium frequency, low-pressure ultrasound that is pulsed with a 20 ms pulse duration to achieve 
bio-effects such as oncotripsy.  Cavitation ultrasound uses low frequency, high pressure, short 
bursts of ultrasound to promote the cavitation of gas-filled cavitation nuclei.  High intensity 
focused ultrasound (HIFU) uses high frequency, high intensity continuous wave ultrasound to 
maximize thermal deposition in tissue. 
 
 Ultrasound cavitation uses high pressure, short pulses to induce a contrast agent to undergo 
a destructive inertial cavitation event.  The most common contrast agent used in lab and clinically 
is a lipid-stabilized microbubble.  This microbubble contains a small volume of gas that maintains 
its cohesion due to its lipid shell.  At high acoustic pressures, the bubbles undergo inertial 
cavitation as described in Chapter 1.  The key ultrasound parameter to achieve cavitation is having 
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a sufficiently large peak-negative-pressure that can exert a tensile force on the contrast agent to 
initiate the inertial cavitation  
Thermal ultrasound uses high intensity, continuous wave ultrasound, generally focused to 
a small area in the body, to deposit acoustic energy as heat through attenuation.  It can be used as 
an ablative therapy such as when HIFU is applied a cancer ablation technique.  However, thermal 
ultrasound has also been evaluated as a non-ablative therapeutic modality.  Local increases in 
temperature have an anti-inflammatory and pain relieving effect that is being studied.  The body 
inherently has many biochemical processes that are sensitive to changes in temperature.  They key 
ultrasound parameter to achieve temperature increase is having a sufficiently large ISPTA (spatial 
peak, temporal average intensity).  That is, an acoustic intensity that pumps a consistent amount 
of thermal power into the body to overcome the natural diffusion and convection in tissue to cause 
a local temperature increase. 
5.2 Ultrasound to Detonate Acoustically Active Biomolecules 
5.2.1 Background 
In work pioneered and published by lead-author Avinoam Bar-Zion, we investigate the 
potential for the genetically-encodable biomolecules to serve as cavitation nuclei.  This approach 
uses gas vesicles (GVs), a unique class of genetically encoded gas-filled protein nanostructures 
that were recently introduced as reporter genes for ultrasound [111] and magnetic resonance 
imaging (MRI) [112]. I had the opportunity to participate in this research project where we 
hypothesized that at lower ultrasound frequencies these biomolecules can also serve as nuclei for 
the formation and cavitation of bubbles, allowing them to serve as therapeutic warheads. My role 
in this project was to use ultrafast microscopy to visualize the cavitation that is induced when high-
pressure ultrasound is incident upon GVs. 
GVs are cylindrical amphiphilic protein shells with diameters ranging from 45 to 250 nm 
and lengths of 100 to 600 nm [113].  These shells are permeable to gas but exclude water due to 
their hydrophobic interior surface (Fig 1a). In nature, photosynthetic bacteria and archaea produce 
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intracellular GVs as a mechanism for regulating buoyancy in response to environmental nutrient 
concentration or sunlight [114].  Purified GVs produce image contrast under high-frequency 
diagnostic ultrasound, based on the special physical properties of their gas-filled interior [115]. 
 
 
Figure 5-2 | Gas vesicles as nuclei for inertial cavitation 
a, Schematic drawing of a GV. The GV’s amphiphilic protein shell encloses a stable, gas-filled 
structure. b, Representative transmission electron microscopy (TEM) images of intact (left) and 
collapsed (right) Anabaena flos-aquae GVs. c, Proposed mechanism of GV-seeded cavitation. 
An ultrasound (US) pulse with a positive pressure higher than the critical collapse pressure, Pcol, 
collapses the GV, resulting in the release of a nanoscale air bubble. The released nanobubble 
undergoes cavitation if the peak negative pressure of the US pulse reaches below the critical 
cavitation pressure, Pcav. Over several cycles, the nanobubble is converted into a micron-scale 
bubble, which can eventually undergo violent inertial cavitation. Scale bar represents 200 nm. 
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The hypothesis that GVs can nucleate bubbles for inertial cavitation arises from the fact 
that GVs collapse under applied acoustic pressure (Figure 5-2b), releasing the air contained inside 
them to the surrounding media. The ability of such collapse to take place at specific pressure 
thresholds, defined by GVs’ DNA sequence and protein composition, has been used for 
background-subtracted molecular imaging [111]. Under most conditions, gas molecules released 
from collapsed GVs are expected to form nanoscale bubbles, which should dissolve within 
milliseconds due to Laplace pressure [116]. However, we hypothesized that at ultrasound 
frequencies in the sub-MHz range, these free bubbles could also serve as seeds for cavitation, a 
process in which bubbles expand and contract during the negative and positive phases of sound 
waves, respectively, and can grow in size through rectified gas diffusion and coalescence [117, 
118]. Such processes are favored at lower ultrasound frequencies and higher peak negative 
pressures. In addition, bubbles can be stabilized by the presence of hydrophobic surfaces [118], 
such as the exposed interior of collapsed GV shells (Figure 5-2b). We envisioned that positive 
pressure above GVs’ critical collapse threshold would break open the GVs to release gas 
nanobubbles, and that negative pressure would then cause these bubbles to grow. At relatively low 
ultrasound amplitudes, the resulting bubbles would undergo stable cavitation – a sustained periodic 
oscillation of gas bubble size. At relatively high amplitudes, the bubbles would undergo rapid 
growth and violent collapse in a process known as inertial cavitation, unleashing powerful 
mechanical effects26 (Figure 5-2c). 
5.2.2 High Speed Camera Experiments 
To more directly visualize the process by which GVs nucleate the formation of cavitating 
bubbles, we imaged this process optically using an ultra-high frame rate camera, acquiring images 
at 5 million frames per second (Figure 5-3a). The GVs were attached to acoustically transparent 
Mylar bottomed dishes using biotin and streptavidin. Before insonation, we observed a dark pattern 
indicative of intact GVs (Figure 5-3b), whose gas interiors scatter visible light [114, 119]. After 
ultrasound was applied and reached sufficient amplitude, this dark pattern suddenly disappeared, 
revealing GV collapse (1.4 – 1.8 μs, Figure 5-3b and Supplementary Fig. 3). 2.4 µs later, we 
observed dark bubbles forming and cavitating inside the field of view (Figure 5-3b), and 
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continuing to grow in the following cycles (Figure 5-3d). Meanwhile, control dishes with biotin 
coating alone failed to show significant cavitation (Figure 5-3c). We further analyzed the videos 
to track the temporal relationship between GV collapse and bubble cavitation. After forming, 
bubbles grew and shrank at the frequency of the ultrasound waves (Figure 5-3d). By comparing 
the phase of the wave at which GVs disappear with the phase of maximal bubble growth rate, we 
could confirm that GVs collapse at the positive pressure peak, while maximal growth of the 
resulting bubbles occurs at the negative peak of the ultrasound cycle, π apart in phase (Figure 5-3e), 
and bubble size peaks at 3/2 π, at the conclusion of rarefaction (Figure 5-3f). Similar results were 
seen across bubbles (Figure 5-3g). This data confirms the ability of GVs to nucleate bubble 
cavitation and supports the mechanistic model depicted in in Fig. 1c. 
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Figure 5-3 | Ultrafast optical imaging of GV-seeded bubble formation and cavitation 
a, Schematic drawing of the high frame rate (HFR) camera setup enabling GV cavitation imaging 
at a frame rate of 5 MHz. b, HFR camera images immediately before GV collapse (left), 
immediately after GV collapse (middle), and after the formation of bubbles (right). c, Number of 
unique cavitation loci in biotinylated dishes with and without GVs, upon insonation with a single 
1.4 MPa burst (p= 0.0411, n=6). FUS pulses with 30 cycles at 0.67 MHz were used unless 
otherwise stated. d, Representative high-speed camera frames showing every other maximum and 
minimum of bubble cavitation, preceded by GV collapse. e, Bubble growth rate, quantified as the 
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temporal derivative of the normalized average inverted pixel intensity in (d) (left). The plot on the 
right shows each maximum in the growth rate aligned to the phase offset from the time of GV 
collapse. f, Bubble size and phase offset from GV collapse analyzed from HFR images as in (e). 
g, Average phase offset for peak size and peak growth rate for three different regions of interest. 
Plots show mean ± SEM (c, g). Scale bar represents 20 μm (b). 
 
5.3 High Intensity Focused Ultrasound for Thermal Control 
5.3.1. Background 
I also had the opportunity to work on a project with Mohamad Abedi on a currently 
unpublished project that uses ultrasound to activate thermally controlled genetic circuits in vivo.  
This project leverages high intensity ultrasound’s capability to cause a local increase in 
temperature in biological tissue.  While the results from this project are unpublished, I have cleared 
with the authors that the following limited information about my involvement in the project can 
be included in this dissertation. 
Many biological processes are highly heat sensitive.  At temperatures above 40-47 °C, cells 
begin suffering from hyperthermia with the initiation of several cell death pathways included heat-
induced apoptosis, alterations in proteins that support DNA metabolism and mitosis, and 
generalized unfolding and aggregation of proteins.  The effects are significantly more profound 
above 43 °C, with an exponential increase in the cell damage and decrease in cell survival times 
as temperature increases.  Temperatures above 48 °C causes thermal ablation or irreversible 
widespread protein unfolding [120].  Thermal ultrasound ablation techniques, such as high 
intensity focused ultrasound, causes hyperthermia of above 60 °C which leads to complete 
coagulative necrosis in that area.  However, cells have the capability to reverse the damage from 
mild hyperthermia through the activity of heat shock proteins [121].  The protein’s expression is 
regulated by heat shock promoters in the DNA that initiate expression in response to increased 
temperatures.  These proteins then initiate a variety of cytoprotective pathways.  However, of 
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interest to many ultrasound researchers is the potential for therapeutic modalities that take 
advantage of the heat shock promoter’s ability to control gene expression in response to 
temperature.  Couple with noninvasive ultrasound, this allows for a completely noninvasive 
method of controlling genetic expression, at depth within the body.  This has many advantages 
over other attempts to control genetic expression at depth, such as optogenetics, as ultrasound has 
greater penetration depth than light does in the human body. 
5.3.2 Thermal Control with PID Circuit 
 My role in this project was to develop the in vivo experimental rig and help to optimize the 
ultrasound parameters in order to activate a genetic circuit based on native heat shock promoters 
placed within a bacterial agent living in tumors in an immunocompromised mouse model.  Details 
about the bacterial agent and genetic circuit are omitted prior to publication.  The experimental 
suspended the mouse in a temperature regulated and degassed water bath maintained at room 
temperature.  A 0.67 MHz HIFU transducer was also placed in the water bath and targeted at a 
target tumor positioned on the lateral flank of the mouse.  A small temperature sensitive fiber optic 
element was placed in the center of the tumor, and used to align the HIFU transducer.   
 In order to achieve the desired bioeffects, we needed to precisely and dynamically control 
the temperature of the tumor.  We developed a confidential temperature activation sequence that 
we found activated the temperature sensitive genetic circuit.  As such, we needed to develop a 
control system that allowed for rapid and accurate adjustment of the ultrasound waveform that was 
supplying the heat to adjust the tissue temperature.  The system we developed was a PID controller 
with anti-windup.  This system controlled the driving voltage for the HIFU transducer, which 
correlates with peak-negative-pressure, in order to cause the measured tumor temperature to track 
with a certain reference temperature that tracked with our temperature activation sequence.  The 
ultrasound waveform used for thermal control was a continuous wave signal with the peak negative 
pressure being actively modulated by a PID control circuit in order to achieve a desired 
temperature in the targeted tissues (Figure 5-4).  This technique has shown promising in vivo 
results that I look forward to sharing once this article is published.  This application of ultrasound 
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required the use of an invasive temperature probe for the temperature feedback required for 
running the PID controller.  This was effective for this proof of concept of the temperature 
activation sequence and the genetic circuit.  However, in a clinically deployable application, we 
would likely use a non-invasive thermometry technique, such as MRI-thermometry which takes 
advantage of the temperature sensitive of MRI contrast within the human body [122]. 
 
Figure 5-4 | PID Control System Used for Thermal Control 
This schema for a PID control system with anti-windup control.  The reference value (r) represents 
the temperature of the thermal activation sequence that we have developed.  This value changes 
over time in accordance with the progression of the thermal activation sequence.  The measured 
value (y) is the temperature measured from the fiber optic probe.  The actuated control parameter 
(u) represents the fraction of maximum voltage that is used to drive the ultrasound transducer.  The 
peak negative pressure of the HIFU is directly proportional to the transducer driving voltage.  
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C h a p t e r  6   
 
CONCLUSIONS AND FUTURE EXPERIMENTS 
 
6.1 Introduction 
In this final chapter, I will describe the conclusion of this investigation of the oncotripsy 
theory.  I shall include plans that I have developed with collaborators for future experiments to 
investigate the mechanism and applicability of oncotripsy theory.  These include further high speed 
camera investigations of the role of cavitation and cell deformation in response to ultrasound, an 
investigation of this procedure being applied to solid tumor contexts in vitro and in vivo, and the 
potential for combinatorial therapy with chemotherapeutics or immunotherapeutics. 
6.2 Investigation of the Mechanism of Oncotripsy 
The experiments outlined in this thesis suggest that cancer-cell selective ablation can be 
achieved through the use of low intensity pulsed ultrasound applied at specific frequencies and 
pulse durations in suspension.  Subsequent experiments suggested that this effect requires the 
ultrasound field to be in the form of standing waves and that cavitation played a mechanistically 
essential role in the cytodisruptive effect.  The theory we propose is that the standing waves 
promote the formation of aggregated cavitation nuclei within the cell suspension, which then 
cavitate in response to ultrasound stimulation.  We hypothesized that this cavitation amplifies the 
acoustic signal of the incident ultrasound wave, thus exposing the cell to mechanical oscillation at 
the incident frequency and leading to the frequency-dependent cytodisruption described in the 
computational simulations referenced in this thesis.  This hypothesis has several testable 
predictions that merit investigation. 
First, while we observed non-linear acoustic scattering using passive cavitation detection, 
this gives limited information about the interaction between the cavitating phenomena and the cells 
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themselves.  Visualization of the bubbles and their physical interaction with the cells would be 
highly instructive in further understanding the mechanistic role that cavitation plays in ultrasound 
oncotripsy.  To this end, I suggest an experiment be performed using the high speed optical 
microscopy setup with 10 Mfps acquisition speed as described in Section 3.6.6.  This microscope 
was effectively able to measure the oscillation of the cells in response to ultrasound, confirming 
no micron-scale deformation that was resolvable by the imaging system.  The imaging cartridge 
used by the system (Figure 3-3) could be modified to ensure that a robust standing wave is being 
generated within the imaging chamber when ultrasound is applied on it.  Then, video can be 
acquired at multiple locations throughout the imaging chambers to search for the dynamics of 
cavitating bubbles.  Micron size bubbles can be easily observed and measured using this setup, as 
depicted in Figure 5-3. The radius over time of the cavitating bubbles and the bubbles distance 
from the surrounding cells may thus be assessed.  Appendix A includes a brief computational study 
using the Keller-Miksis equation to predict the cavitation bubble size and bubble distance from 
surrounding cells necessary to achieve a scattered cavitation signal that amplifies the incident 
ultrasound wave.  This simulation predicts that bubble sizes should be on the order of micrometers 
may be necessary for significant signal amplification which should be visible on microscopy.  
However, there is some literature suggests that nano-bubble cavitation, especially stabilized by 
lipids, may also have mechanical transduction effects in biological tissue [123], so the absence of 
visible bubbles in the presence of a inertial cavitation signal detected by passive cavitation 
detection may be notable as well.  
Further high speed microscopy experiments could provide further insight into the 
cytoskeletal cycle fatigue model predicted by the oncotripsy model as well.  The images previously 
acquired lacked the contrast necessary to image intracellular elements.  The insight that there was 
no micron-scale cellular deformation was made by observing the plasma membrane of the cell 
which was made visible using transmitted light microscopy using a laser illumination source.  
However, there are many ways to increase the image contrast to allow visualization of sub-cellular 
components.   Pigment dyes such as methylene bind to the DNA of permeabilized cells [124], and 
may be applied immediately prior to insonation to visualize nuclear movement.  Pigment dyes 
have the advantage of enhancing contrast in transmitted light microscopy setups, however, we 
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have done some preliminary experiments involving high speed fluorescence microscopy using a 
photo-multiplier tube intensifier as described in Figure 6-1. 
 
Figure 6-1 | Proposed setup for high speed fluorescence imaging 
Epifluorescence imaging performed using mercury lamp illumination (Atlanta Light Bulb) and a 
Chroma EGFP filter set (Chroma #IN005873) that passed through water immersion microscope 
objective and concentrated on biological sample within water bath.  Emitted fluorescent light was 
amplified through the use of the LaVision HighSpeed IRO intensifier, which coupled to the 
Shimadzu HPV-X2 camera. 
 
In our exploratory experiments, the high speed camera used for the transmitted light 
microscopy (Shimadzu HPV-X2 camera) had insufficient sensitivity to detect the epi-fluorescence 
signal from powerful Alexa fluorophore dyes when 100 ns exposure time required for high speed 
imaging.  With the introduction of the IRO intensifier running at maximum brightness and 
intensifier gain, we were able to get a very grainy image of  5 μm diameter AlexaFluor polystyrene 
beads at 200 ns exposure time.  Future experiments may use more powerful fluorescent tags, such 
as quantum dots [125, 126], or aim to refine the fluorescent microscopy setup through 
collaborations with laboratory groups that have perfected the procedure [127].  Fluorescent 
microscopy would enable the use of fluorescent dyes that could be tagged to the sub-cellular 
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components.  This could allow tracking of the differential movement of the nuclear membrane and 
cytoplasmic membranes, which would provide greater insight into the mechanical transduction of 
acoustic energy into the cell and perhaps validate the theory of cyclic fatigue being applied to the 
cell’s cytoskeleton.  Fluorophores may also allow tracking of cytoskeletal elements and be able to 
document cytoskeletal disassembly during insonation. 
 
Figure 6-2 | Poor image acquisition of fluorescent dyes with high speed microscopy 
Image of 5 μm diameter AlexaFluor polystyrene bead (upper left) from 200 ns exposure with 100x 
water immersion objective using epifluorescence microscopy setup described in Figure 6-1 
 
In summary, the use of high speed microscopy, especially when coupled with strategies to 
enhance the contrast of sub-cellular components, can provide evidence to test the theory of cell-
mediated cavitation leading to cytodisruption through incident ultrasound signal amplification and 
cytoskeletal cyclic fatigue. 
6.3 Application of Oncotripsy to Solid Tumor Models  
While oncotripsy provides a framework for developing a LIPUS waveform that has proven 
cancer selectivity in suspension cells, there are still many steps that must be taken before it can be 
considered as a serious clinical tool.  The capability for oncotripsy theory to hold in solid tumor 
context must be investigated as well.  The tumor microenvironment is heavily defined by the 
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extracellular matrix that cancer cells reside within.  This extracellular matrix is comprised of a 
mechanically complex environment of macromolecules including collagen, elastin, and 
proteoglycan that has significant implications for disease progression [128].  More over the cells 
are interconnected within this extracellular matrix and thus mechanical forces that are applied on 
the matrix are transduced to the cells and have documented effects on intracellular processes [129]. 
When considering the effect of acoustic waves on cells, it thus seems extremely important to 
incorporate the mechanical properties of the extra-cellular matrix.  The transient response model 
developed by Heyden incorporated the extracellular matrix as an elastic continuum within which 
the cells resided.  The finite element model developed in this framework still did exhibit a 
frequency-dependent cellular response to ultrasound.  However, the first experimental 
investigation of this effect was primarily in suspension cells.  One experiment performed with the 
cancer cells suspended in a solid medium of agarose, which is a poor model for the complex and 
interconnected tumor extra-cellular matrix environment, demonstrated only that the same 
waveform that induces cytodisruption in suspension induces a greatly attenuated effect in agarose.  
This result could be predicted in that the change in the extra-cellular mechanical properties should 
change the cells inherent mechanical response to ultrasound.  Dedicated research in solid tumor 
contexts are necessary to further this understanding, and are currently being undertaken by Jian 
Ye and Dr. Peter Lee’s group in City of Hope.  Solid models can be developed in vitro using 
collagen-agarose hydrogels that simulate the mechanical properties of tumor tissue [31, 32] or 
through more complex models involving spheroids [130, 131] or ex vivo tissue samples.  
Alternatively, we may find it useful to jump to pre-clinical mice models, which limit the potential 
throughput of experimentation, but may serve as an early check to confer the viability of ultrasound 
oncotripsy as a valid method for cancer therapy in relevant clinical contexts. 
6.4 Synergistic capabilities of oncotripsy with chemotherapy and immunotherapy 
 Secondly, safely implementing oncotripsy as a non-invasive, inherently selective cancer 
ablation system has remarkable potential in its synergistic capabilities with current therapeutic 
modalities.  Oncotripsy theory would predict that cancer cells would be exposed to greater 
cytoskeletal damage from LIPUS compared to healthy cells at target waveforms.  Cytoskeletal 
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damage may correspond to increased membrane permeability to chemotherapeutics.  
Pharmaceutical companies must overcome inherent challenges in cellular drug uptake and balance 
drug potency versus non-specific effects.  Numerous anti-cancer drugs, including large protein 
biologics, must enter into the cellular cytoplasm in order to be effective.  Moreover, research 
performed on the mechanical side effects of high intensity focused ultrasound (HIFU) suggests 
that mechanical ultrasound ablation releases antigens that may activate a systemic immune 
response [132].  Our in vitro experimental evidence included enhanced pro-phagocytic and 
apoptotic pathways are activated by LIPUS, which lends credence to this potential for combined 
therapy.  As such, there may be a role for immunotherapy drugs that assist in the formation of a 
systemic anti-neoplastic immune response, such as anti-PD1 or TLR9 [104].  As such, a key next 
step for the oncotripsy project includes testing the hypothesis of enhanced chemotherapeutic 
uptake in cancer cells by observing synergy between chemotherapeutic agents and LIPUS 
cytodisruption.  Next, we should investigate whether LIPUS-killed cancer cells can confer 
protective immunity in an immunocompetent mouse model.  This can be done with cancer cells 
killed in vitro and then injected into the mouse as described in [133], or once the ideal ultrasound 
parameters for in vivo cytodisruption are determined, LIPUS could be applied in vivo while the 
effect on a contra-lateral non-treated tumor could be observed as a metric for systemic immune 
response. 
6.5 Closed loop device for tuning oncotripsy parameters  
 Finally, a future goal for oncotripsy may involve recognizing the patient-to-patient 
variability inherent in any cancer therapeutic technique and developing a combined non-invasive 
imaging and therapeutic system that can apply the optimum US parameters for oncotripsy.  We 
have access to several elastography systems that can be used to non-invasively probe the 
mechanical properties of tissue such as US elastography or magnetic resonance elastography [134].  
The Shapiro lab has experience with elastography imaging. Such techniques can be performed on 
in vitro / ex vivo samples [135] or within in vivo contexts without requiring invasive biopsies [136].  
We plan to perform high-resolution scans using various imaging modalities and correlate the 
imaging results with in vitro and in vivo cell disruption as assessed through our previously 
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validated models.  We hypothesize that patterns from these scans can be correlated to the 
parameters necessary for targeted therapy.  This would be the first step to developing a closed-
loop device that can apply targeted therapy to account for cancer pleomorphism.  
6.6 Conclusion 
A non-invasive US system that can selectively increase the membrane permeability of 
target cells to uptake the drug of interest and enhance the local immune response through epitope 
release could have a massive synergistic effect in combined therapy.  This therapy could have 
significant clinical benefits, particularly in clinically challenging tumors such as glioblastoma 
multiforme, where tumor invasion make complete surgical resection challenging and drug uptake 
can be poor [70].  Combining local surgical resection with regional oncotripsy that selectively 
targets rogue cancer cells and systemic chemotherapy/immunotherapy could remove the bulk 
tumor and address micro-metastasis that lead to recurrence.   
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APPENDIX A: KELLER-MIKSIS SIMULATION OF CAVITATING 
BUBBLE IN ULTRASOUND FIELD 
The Keller-Miksis equation is a differential equation that describes the large radial 
oscillations of a bubble in a continuum of liquid that is exposed to an acoustic pressure field.  This 
particular model suits our investigation of bubble cavitation in long pulse duration ultrasound 
fields, at our pressure and frequency ranges, and as such will be a good approximation for what 
can be expected in future experimental work investigating the oncotripsy method [137].  Our goal 
for this simulation is to determine whether the ultrasound waveform that was measured to induce 
cancer-cells selective cytodisruption (0.5 MHz, 1.4 MPa PNP due to standing wave condition) can 
stimulate a bubble to emit an acoustic signal that would act to amplify the 0.5 MHz mechanical 
signal a nearby cell would experience. 
We will use the protocol described here [138] in order to model the acoustic emission of a 
cavitating bubble using the following set of equations: 
 
R = instantaneous bubble radius, as a function of time 
t = time 
c = speed of sound in media 
ρ = density of water 
pw = pressure at bubble wall 
 
 
σ = surface tension between gas-water interface 
η = dynamic viscosity of water 
R0 = equilibrium radius 
κ = polytropic exponent 
Pa = pressure amplitude of the driving HIFU 
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Prad = acoustic emission 
r = distance from the bubble center to the target location 
 
Experimental data from [138] of bubble radius over time in response to similar ultrasound 
conditions is used to verify the validity of the Keller-Miksis equation in this context (Figure A-1). 
 
 
Figure A-1 | Validation of Keller-Miksis Model 
Top graph reproduced from [138] includes experimental data for bubble radius over time for 1.31 
MPa, 698 kHz HIFU applied on 3 μm bubbles with black circles and the Keller-Miksis model 
prediction in red.  Bottom graph shows the Keller-Miksis model used in this appendix using R=3 
μm, ρ=998 kg/m3, η=1e-6 m2/s, σ=0.072 N/m, c=1484 m/s, P0=101 kPa, Pa=1.31 MPa showing 
strong agreement with experimental data and published Keller-Miksis models. 
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For this simulation, we will test a range of bubble sizes with radii in the nanometer and micrometer 
scale, and assess the pressure emitted at distances ranging from the micrometer to millimeter scale.  
This will provide insight into whether pressure emissions from these cavitating bubbles will serve 
to amplify the input ultrasound signal and lead to frequency dependent cytodisruption. 
 
 
 Name Value 
   
 Variables  
T time [s] 
R(t) instantaneous bubble radius [m] 
pw(R,t)  pressure at bubble wall [Pa] 
Prad (R,t) pressure acoustic emission [Pa] 
   
 Constants  
c  speed of sound in media 1500 m/s 
ρ  density of water 997 kg/m3 
σ  surface tension between gas-water 
interface 
72.86 mN/m 
κ  polytropic exponent 1.4 (adiabatic expansion) 
Pa  pressure amplitude of the driving HIFU 1.4 MPa 
η dynamic viscosity of water 1.004 * 10-6 m2/s 
   
 Sweep Parameters  
R0  equilibrium radius 10-8 – 10-5 m 
r  distance from the bubble center to the 
target location 
10-6 – 10-2 m 
 
Table A-1 | Variables and Coefficients for Keller-Miksis Simulation 
 
Using this Keller-Miksis model, we can simulate the frequency spectra of the acoustic 
emissions with various equilibrium radius bubbles at various distances from the bubble center.  
The code for this simulation is available in the GitHub referenced in Appendix B.  Matlab’s stiff 
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ordinary differential equation solver, ODE15s, was used to solve the differential equation 
described by equations (1) and (2) to determine the bubble radius and its derivative over time after 
exposure to insonation.  A simplifying simplification of a non-viscous fluid.  These values were 
used to calculate the acoustic emission of the bubble at various diatances using equation (3).  The 
0.5 MHz component of the acoustic emission at a specific distance from the cavitating bubbles 
was compared to that of the applied ultrasound signal.   
 
Figure A-2 | Keler-Miksis Simulated Cavitating Bubble Evolution and Pressure Emission  
Keller-Miksis simulation results showing evolution of radius over time given an initial radius of 
0.102 micrometers and the FFT of the pressure produced from that signal.  This demonstrates the 
highly nonlinear response to ultrasound stimulation and the large variation in bubble size. 
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Figure A-3 | Keller-Miksis Simulated Amplification of Incident Ultrasound Pressure 
Keller-Misis simulation results showing decibel gain in the 0.5 MHz FFT of the pressure emissions 
from cavitating bubbles compared to the stimulating ultrasound signal.  Initial bubble radius on 
the y-axis and distance from the bubble on the x-axis.  In red regions the cavitating bubble’s 
emitted pressure has a larger FFT signal at the stimulation frequency than the ultrasound signal. 
 
The simulation results (Figure A-3) suggest that bubbles with radii greater than ~100 nm 
evoke pressure emissions that amplify the driving ultrasound signal within ~10 μm.  While bubbles 
in this initial size range may be challenging to detect via optical microscopy, the simulation 
suggests that the bubble size may greatly expand during insonation.  A bubble radius beginning at 
0.1 μm may grow to 25 μm during insonation, which would be easily detectable through 
microscopy techniques (Figure A-2).    
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As such, further experiments using high speed microscopy could observe and track the 
cavitation bubbles radii over time during ultrasound stimulation.  This could be used to calculate 
the pressure field that cells experience during insonation and correlate that with the cytodisruption 
caused by oncotripsy.  An important finding to consider is that while the cavitating bubble 
primarily amplifies the driving signal at the driving frequency of the ultrasound, the emitted 
pressure signal does not solely contain that frequency.  Instead, there are multiple harmonic peaks 
present on the FFT spectrum for pressure emitted from the cavitating bubble, which is an expected 
finding considering that cavitation is an inherently non-linear response.  Future oncotripsy 
computational studies that model the cellular response to this phenomenon may want to consider 
this more complex pressure waveform, rather than the single frequency sinusoidal waveform of 
the driving ultrasound signal. 
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APPENDIX B: SCRIPTS, PROTOCOLS, AND MODELS ON GITHUB 
For the reference of any experimenters who wish to adapt some of the computer scripts, 
experimental protocols, or CAD models that I have developed throughout my work on this project, 
please see attached to thesis archived versions of the following entries in the CaltechDATA 
repository: 
oncotripsy This repository includes scripts that simulate cavitating 
bubbles' amplification of incident ultrasound pressure 
waves. 
 
ultrasound_hardware_control Scripts that allow the user to conduct ultrasound 
experiments 
 
ultrasound_rigs Solidworks models that may be useful in designing 
ultrasound experimental rigs. 
 
thermal_control This repository includes scripts that allow the user to 
conduct thermal ultrasound experiments with closed loop 
control using a PID with anti-windup control system. 
 
 
Updated versions of these repositories are available on my personal Github page: 
https://github.com/drmittelstein 
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